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Exploring Colorectal Cancer Diagnosis Disclosure to First-Degree Relatives:
An African American Family Case Series
Kamilah B. Thomas
Abstract
Colorectal cancer (CRC) is the second leading cancer killer in the United States and the 
third most common cancer in African American men and women. Though the overall 
death rates have declined, this reduction in mortality is smaller for African Americans 
than for Whites. Factors that are protective against colorectal cancer include 
occupational or recreational physical activity, a diet high in fruits and vegetables, and 
colorectal cancer screening with removal of polyps (polypectomy) before they progress 
to cancer. Compliance with CRC screening recommendations requires people to know if 
a first-degree relative (parent, sibling, and child) or second-degree relative (aunt, uncle, 
niece, nephew, and grandparent) has been diagnosed with colorectal cancer. Little is 
known about how patients disclose this information to their relatives and what type of 
information is disclosed when disclosure takes place. The role of the family has long 
been overlooked in research on African American health screening behavior despite the 
fact that family interventions have been known to produce favorable outcomes in diet, 
nutrition, and exercise. This qualitative study explored the disclosure process among 
African American colorectal cancer survivors and FDRs with whom they shared their 
diagnosis. Of special interest was the role of social support in the disclosure process and 
the criteria used to decide which relatives to tell. Findings from this study will be used to 
vii
advance the knowledge about the dynamics of CRC disclosure to first-degree relatives in 
African American families and ultimately increase CRC screening in relatives.
1Chapter One
Introduction
The overall health of the United States (U.S.) population lags behind that of 
most industrialized nations due to the persistent and growing disparities in mortality, 
morbidity, and disability between Whites and people of color (Brulle & Pellow, 2006).
African Americans bear a disproportionate burden of many health problems.  Morbidity 
and mortality are higher among African American men than any other racial or ethnic 
group (Plowden & Miller, 2000).
Colorectal cancer (CRC) is of particular importance because it is the third leading 
cancer killer in the United States (American Cancer Society [ACS], 2009) and the third 
most common cancer in African American men and women (ACS, 2007).  CRC is a 
disease in which malignant (cancer) cells form in the tissues of the colon or the rectum 
(National Cancer Institute [NCI], 2008). An estimated 7,120 deaths from CRC were 
expected to occur in 2009 among African Americans (ACS, 2009). The higher death rates 
account for one-fourth of the disparity in cancer death rates between African-American 
and white women and 11% of the disparity between African American and white men 
(ACS, 2007). Though the overall death rates have declined, this reduction in mortality is 
smaller for African Americans than for Whites. Chen et al. (1997) conducted a cancer 
survival study and found that blacks have a poorer colon cancer survival rate than white 
patients and have a more advanced stage of disease at diagnosis.  
2An estimated 16, 440 cases of colorectal cancer occurred among African 
Americans in 2007 (ACS, 2007). Incidence rates among African American men and 
women are higher than those among whites (ACS, 2007). Though the exact causes of the 
disparity are unknown, there are several factors that increase the risk of colorectal cancer 
including obesity, physical inactivity, cigarette smoking, a diet high in red or processed 
meat, and heavy alcohol consumption (ACS, 2007, p. 10). Additionally, relatives of CRC 
patients have an increased risk of the disease with increasing strength of family history 
and younger age of diagnosis in relatives (ACS, 2007; NCI, 2008).
Improved preventive care may have an impact on narrowing the colon cancer 
incidence and survival gaps in the African American population. Factors that are 
protective against colorectal cancer include occupational or recreational physical 
activity, a diet high in fruits and vegetables, and colorectal cancer screening with 
removal of polyps (polypectomy) before they progress to cancer (ACS, 2009).
Therefore it is important for African American men and women to engage in healthy 
behaviors that allow for prevention and early detection of colon cancer. 
Screening Recommendations
An overview of the screening guidelines recommended by professional health 
organizations may provide further background on this important issue. The American 
Cancer Society, the American College of Radiology, and the U.S. Multi-Society Task 
force on Colorectal Cancer (a consortium representing the American College of 
Gastroenterology, the American Society of Gastrointestinal Endoscopy, the American 
Gastroenterological Association, and representation from the American College of 
Physicians) collaborated on updated consensus guidelines in March 2008 (ACS, 2008).
3The new guidelines distinguish between screening tests that primarily detect cancer and 
those that are more likely to detect both cancer and adenomatous polyps (ACS, 2008).
The updated guidelines recommend men and women at average risk for CRC to begin 
screening at age 50 using one of the following preferred tests to screen for polyps and 
cancer: 1) flexible sigmoidoscopy every 5 years, 2) colonoscopy every 10 years 3) 
double-contrast barium enema every 5 years, or 4) CT colonography (virtual 
colonoscopy) every 5 years (ACS, 2008; Levin et al., 2008). The USPSTF (2008) 
recommends screening for colorectal cancer using fecal occult blood testing, 
sigmoidoscopy, or colonoscopy in adults, beginning at age 50 years and continuing until 
age 75 years.
The following tests are primarily effective at detecting cancer alone because the 
opportunity for prevention is limited and not the primary goal: 1) fecal occult blood test 
(FOBT) annually, and 2) Stool DNA test which currently has an uncertain test time 
interval.
Screening at an earlier age is recommended for those who have a first-degree 
relative (FDR) with a history of colorectal cancer or polyps younger than 60 years of age, 
two FDRs of any age with a history of CRC, or a family history of familial adenomatous 
polyposis or hereditary non-polyposis colon cancer (Read & Kodner, 1999). The United 
States Preventive Services Task Force (USPSTF) has determined that the net benefits of 
screening is substantial for adults age 50 to 75 years (2008). However, updated USPSTF 
guidelines recommends against routine screening for colorectal cancer in adults ages 76-
85 (USPSTF, 2008).
4For people with increased risk, compliance with these screening recommendations 
requires people to know if a first-degree relative (parent, sibling, child) or second-degree 
relative (aunt, uncle, niece, nephew, and grandparent) has been diagnosed with colon 
cancer (Forrest et al., 2003). When people do not share information about cancer 
diagnosis or genetic testing information with relatives at risk, relatives are denied the 
possibility of taking appropriate preventive measures (Forrest et al., 2003). Research has 
found that most patients disclose genetic testing information to their first- degree and 
second-degree relatives (Hallowell et al., 2005).  A general but central research question 
for this dissertation is what decision making criteria do patients use to help them decide 
to disclose or not disclose a cancer diagnosis with family members other than their 
spouse?
Need for the Study
For FDRs with increased CRC familial risk to adhere to the recommendation to 
be screened at an earlier age, knowledge of a first-degree relative’s CRC diagnosis is 
important for determining the appropriate time to be screened. Research has found that 
most patients disclose genetic information to their first degree and second-degree 
relatives (Hallowell et al., 2005). Though research has provided information about which 
family members may receive genetic information, little is known about how patients 
disclose this information to their relatives and what type of information is disclosed when 
disclosure takes place (Hallowell et al., 2005). This is especially true for families in 
which men, rather than women, are at risk (Hallowell et al., 2005).
The role of the family has long been overlooked in research on African American 
health screening despite the fact that family interventions have been known to produce 
5favorable outcomes in diet, nutrition, and exercise (Salminen, Vahlberg, Ojanlatva, & 
Kivela, 2005). The social context of the family has an important and unique influence on 
individual and general practitioner consultation behavior (Cardol et al., 2007). In 
addition, the World Health Organization (WHO, 1976) has characterized the family as 
“the primary social agent in the promotion of health and well-being” (p. 17).
Given the important role of family influence on health behavior, health 
professionals may lean towards encouraging patients to disclose a CRC diagnosis to first-
degree relatives. Research suggests that people refrain from disclosing sensitive 
information because of the need for self-protection or other protection (Afifi, Olsen, & 
Armstrong, 2005).  For instance, if a family member reacts aggressively, individuals may 
refrain from revealing a secret for fear of judgment and ridicule, or fear the information 
may be used against them (self-protection) (Afifi, Olson, & Armstrong, 2005). In 
addition, individuals may fear that the disclosure will hurt the target of the disclosure, 
damage their relationship with that person, or impact other family members (other-
protection) (Afifi et al., 2005). Therefore, it is important to understand the dynamics of 
disease disclosure from the patient’s perspective in order for health professionals to 
understand the pros and cons of disease disclosure and the effects of disclosure on the 
patient.
This study explored the disclosure process among African American colorectal 
cancer survivors and FDRs with whom they shared their diagnosis. Of special interest 
was 1) the role of social support in the disclosure process and 2) the criteria used to 
decide which relatives to tell. Findings from this study will be used to advance the lack of 
knowledge about the dynamics of CRC disclosure to first-degree relatives in African 
6Americans. The findings contribute to an understanding of the disclosure decision-
making patterns among African Americans.  Understanding the positive and negative 
impacts of CRC diagnosis disclosure among African Americans will lead to the 
identification of appropriate recommendations for disease disclosure to a first-degree 
relative. Additionally, an increased understanding of the criteria one uses to make a 
decision about CRC disclosure will contribute to the development of culturally relevant 
interventions that contribute to narrowing the CRC health disparity among African 
Americans.  
Theoretical Basis of the Study
Social support. Social support has been identified as an important factor in 
cancer survivorship. A diagnosis of cancer affects the individual diagnosed as well as 
his/her family and others in his/her social network.  Social support has been defined and 
measured in many different ways. Cobb (1976) defines social support as information 
from others that tells a person he or she is cared for, loved, esteemed, and part of a 
network of social obligations. According to House (1981) social support is the functional 
content of relationships which can be categorized along four basic types of support 1) 
Emotional support involves the provision of empathy, love, trust, and caring; 2) 
Instrumental support involves the provision of tangible aid and services that directly 
assist a person in need; 3) Informational support is the provision of advice, suggestions, 
and information that a person can use in addressing problems; 4) Appraisal support 
involves the provision of information that is useful for self-evaluation purposes, that is, 
constructive feedback, affirmation, and social comparison. Uchino (2004) notes that 
whereas many aspects of social support are defined separately in theory, these functions 
7of social support are associated with each other, and not easily divisible in daily life. 
Additionally, relationships that provide one type of support often also provide other 
types. Though the parts of social support are difficult to examine separately, the 
importance of social support for patients diagnosed with cancer warrants further research 
and was examined in this study.  This is especially relevant when it comes to revealing 
private information such as a colorectal cancer diagnosis that may be deemed as a 
“family secret.”
Family secrets. Family secrets or private information within families can have 
important and relational consequences. The potential consequences that accompany the 
disclosure of a family secret make decisions about whether to reveal such information 
quite complex.  According to Vangelisti, Caughlin, & Timmerman (2001), individuals 
who are thinking about whether to disclose information to a family member have many 
factors to consider. Vangelisti et al. (2001) reviewed criteria that individuals use to 
determine whether to reveal information deemed personal or intimate. It was found that 
people are most likely to reveal secrets when: 1) the secrets threaten their own well-being 
both physically and psychologically; 2) the anticipated response from a confidant is 
positive; 3) the communication context creates an opening or an opportunity for 
disclosure; 4) the impact of the disclosure on family members is positive such as 
receiving social support; and 5) when the disclosure itself brings some reward such as an 
empathetic response or social validation because the secret keeper has the ability to grant 
access to another.
8Purpose of the Study
Given the importance of understanding CRC disease disclosure and the correct
CRC screening intervals, this research examined the disclosure process among African
American colorectal cancer patients. The specific research questions follow.
Patient Research Questions
Question 1: What factors influence patients’ decisions to reveal a CRC diagnosis to 
family members?
Question 2: What decision-making criteria do patient’s use to help them decide to 
disclose or not disclose a CRC diagnosis (including whether disclosure: a) threatens the 
patient’s well-being; b) the anticipated response from a confidant is positive; c) the 
communication context creates an opening as in finding an opportunity for disclosure; d)
the impact of the disclosure on family members is positive such as receiving social
support; and e) when the disclosure itself brings some reward such as social validation)?
Question 3: What roles do emotional, instrumental, informational, and appraisal types of 
social support play in a patient’s decision to disclose his/her diagnosis to an FDR?
9First-degree Relative Research Questions
Question 4: How do FDRs perceive the information they received about the patient’s
diagnosis?
Question 5: How do diagnosed patients influence the screening behaviors of their FDRs 
through emotional support, instrumental support, informational support, and appraisal 
support?
Study Assumptions
1. The patients reported their experiences with CRC disclosure to the best of their 
knowledge/memory and did not falsify their recollections.
2. The FDRs reported their perceptions and the effects of learning about their family 
member’s diagnosis to the best of their knowledge/memory and did not falsify their 
recollections.
Study Delimitations
The following delimitations were imposed on this study:
1. Results from the qualitative data by definition cannot be generalized to all African 
American colorectal cancer patients. 
2. Colorectal cancer patients had to be at least 18 years of age.
3. Colorectal Cancer patients had to be six months to 4 years post treatment.
4. Colorectal cancer patients could not be going through active treatment at the time 
of the study.
5. Colorectal cancer patients had to have at least one living first-degree relative.
6. First-degree relatives (parent, sibling, or child) had to be at least 18 years of age.
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7. First-degree relatives (parent, sibling, or child) could not have a personal history of 
colorectal cancer.
Study Limitations
The following are limitations of this study:
1. Patients and family members who participated in the interview may have been 
motivated to respond due to their positive or negative attitudes about disclosure.
2. Results of the study cannot be generalized to all patients with colorectal cancer or 
all family members of colorectal cancer patients.
3. Results from the study are based on self-reports, which are based on recall of events 
six months to five years in the past.
Definitions of Relevant Terms
African American: African American will be defined as those people who identify as 
being black and live in the United States. This may also include men and women who do 
not self-identify as being African American such as Afro-Caribbeans and Africans.
ATLAS.ti®: ATLAS.ti® is computer software used for the qualitative analysis of large 
bodies of textual, graphical, audio, and video data. It offers sophisticated tools to manage, 
extract, compare, explore, and reassemble meaningful segments of large amounts of data 
in flexible and creative, yet systematic ways. The program provides tools that let the user 
locate, code, and annotate findings in primary data material, to weigh and evaluate their 
importance, and to visualize complex relations between them.
Colorectal Cancer (CRC): Colorectal Cancer is a disease in which malignant (cancer) 
cells form in the tissues of the colon or the rectum (NCI, 2008).
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Colorectal Cancer Treatment: Colorectal Cancer Treatment will be defined as primary 
surgery on the colorectal area with curative intent or any type of radiation or 
chemotherapy treatment.
Disclosure: Disclosure will be defined as sharing information about a CRC diagnosis 
with someone other than a healthcare professional.
First Degree Relative (FDR): First-degree relative will be defined as a biological parent, 
sibling, or child.
St. Joseph’s Hospital Cancer Institute (SJHCI): St. Joseph’s Hospital (SJH) is the largest
hospital in the Tampa Bay area accredited by the American College of Surgeons. SJHCI
provides advanced technology and cancer care (SJH, 2010).
H. Lee Moffitt Cancer Center and Research Institute (HLMCC): Moffitt Cancer Center 
and Research Institute is a National Cancer Institute (NCI) Comprehensive Cancer
Center, located in Tampa, FL. Moffitt focuses on the development of early stage
translational research aimed at the rapid translation of scientific discoveries to benefit
patient care (H. Lee Moffitt Cancer Center & Research Institute [HLMCC], 2007).
12
Chapter Two
Literature Review
The following literature review will provide a historical overview of health 
disparities in the United States. Next, the impact of health disparities on cancer morbidity 
and mortality will be discussed with a focus on colorectal cancer and colorectal cancer 
screening rates and barriers. An overview of the theoretical frameworks that guided the 
study will be provided including if and how they have been used to address colorectal 
cancer in the past. Finally, the empirical evidence examining diagnosis disclosure is 
discussed, including an explanation of the gaps in the literature and a discussion on how 
this study attempted to address them.
Health Disparities in the U.S. Defined
The National Institutes of Health (NIH) defines health disparity as “the 
differences in the incidence, prevalence, mortality, and burden of disease and other 
adverse health conditions that exist among specific population groups in the United 
States” (2009).  In 2000, United States Public Law 106-525, also known as the "Minority 
Health and Health Disparities Research and Education Act," provided a legal definition 
of health disparities:
A population is a health disparity population if there is a significant disparity in 
the overall rate of disease incidence, prevalence, morbidity, mortality or survival 
rates in the population as compared to the health status of the general population.
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In the U.S., slavery was rationalized on the basis of racism, an ideology of 
oppression based on a belief in the inherent biological inferiority of one race and the 
superiority of another (Fiscella & Williams, 2004). The vestiges of slavery are revealed 
in the health status of African Americans in the U.S. given that biological or inherited 
differences associated with race make only a minor contribution to the disparate cancer 
burden among African Americans in the U.S. (ACS, 2007). Genetic variation within race 
is greater than between races (Freeman, 1998); however, life expectancy, morbidity, and 
mortality seem to place the burden of illness and disease on certain segments of the 
population.  
Psychosocial Factors and Health Disparities
In 1990 the life expectancy at birth for the white population was seven years 
longer than for the black population. By 2007 the difference decreased to 4.6 years 
(National Center for Health Statistics [NCHS], 2009). Though the gap in life expectancy 
between the black and white populations has narrowed, disparity still exists. The overall 
mortality was 25% higher for black Americans than for white Americans in 2007 and the 
age-adjusted death rates for the black population exceeded those for the white population 
by 48% for stroke, 31%  for heart disease, 21% for cancer, 113% for diabetes, and 786%
for HIV disease (NCHS, 2009). These statistics provide the evidence that disparities in 
health exist. 
Many of the causes of disparity point to socioeconomic differences. When 
socioeconomic factors are controlled, disparities diminish significantly and disappear 
altogether in some cases (Smedley, Stith, & Nelson, 2003). However, the majority of 
studies find that racial and ethnic disparities remain even after adjustment for 
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socioeconomic and other healthcare access-related factors (Smedley et al., 2003). “If one 
racial, ethnic or other population has a lower use rate even among the insured members of 
the group, it could be that other barriers to access including availability, overt or covert 
discrimination, care-seeking behaviors, or barriers that are difficult to measure, may be 
obstacles to care” (p. 6).  In addition to access, health practices, psychosocial stress, and 
environmental exposures contribute to disparity. Given this reality, it is important to 
acknowledge that racial and ethnic disparities are found in many sectors of American life. 
African Americans, Hispanics, American Indians, and Pacific Islanders, and some Asian-
American subgroups are disproportionately represented in lower socioeconomic ranks, in 
lower quality schools, and in poorer-paying jobs (Smedley et al., 2003).
Biology and Health Disparities
Many of the health disparities relate to disease that can be managed with adequate 
primary care and early detection. It is clear that biologic and phenotypic differences exist 
among the defined racial groups in the United States. Blacks suffer disproportionately 
from elevated blood pressure and cholesterol, as well as illnesses linked to coronary 
artery disease that can be treated with early intervention (Blanchard & Lurie, 2005). In 
addition, the combined death rate for all cancers in 2003 continued to be 35% higher in 
African American men and 18% higher in African American women than in white men 
and women (ACS, 2007). Though these statistics are clear, they track poorly with 
genetics (Brawley & Moore, 2006).
A closed society will conserve genetic traits within that society (Brawley & 
Moore, 2006). This is exemplified by populations in the U.S. that were segregated on the 
basis of race, ethnicity, economics, or other factors (Brawley & Moore, 2006).  It has 
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been advised that the majority of genetic differences correlated or associated with race 
should be considered familial and not racial (Brawley & Moore, 2006) because race is 
not a biological construct, it a social construct that precisely captures the impacts of 
racism (Jones, 2000).
Race and Health Disparities
Many U.S. research studies document disparities in health status based on race. 
Race is a rough proxy for socioeconomic status, culture, and genes that captures the 
social classification of people in a race-conscious society as the U.S. (Jones, 2000). Jones 
(2000) offers a basic framework for understanding racism and its influence on health. 
According to Jones (2000), institutionalized racism comes in two forms: 1) material 
conditions and 2) access to power. “Examples of material conditions include access to 
quality education, sound housing, gainful employment, appropriate medical facilities, and 
a clean environment” (p. 1212).  Examples of access to power include differential access 
to information (including one’s own history), resources (including wealth and 
organization infrastructure), and voice (including voting rights, representation in 
government, and control of media) (Jones, 2000).
Personally mediated racism is defined as “prejudice and discrimination where 
prejudice means differential assumptions about the abilities, motives, and intentions of 
others according to their race” (Jones, 2000, p. 300). Personally mediated racism can be 
intentional and unintentional and includes acts of commission such as surprise at 
competence and omission such as poor or no service. Internalized Racism is defined as 
“acceptance by members of the stigmatized races of negative messages about their own 
abilities and intrinsic worth” (Jones, 2000, p. 300).  Not believing in others who look like 
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them, and not believing in themselves characterize it. According to Jones, 
institutionalized racism is the most fundamental of the three levels because once 
institutionalized racism is addressed, the other levels will cure themselves over time.  
Health Disparities and Cancer
Racial differences have also been found in the quality and intensity of healthcare 
and diagnostic services for a broad range of procedures and disease areas even after 
adjusting for insurance status and severity of disease (Smedley et al., 2003).  This is 
particularly important for cancer because it is best controlled by prevention through 
avoidance of exposures to cancer- causing agents and early detection (Brawley & Moore, 
2006). Insurance status has emerged as a key predictor of the quality of care that patients 
receive and those with a private source of insurance generally receive a higher quality of 
care (Smedley et al., 2003). Racial and ethnic minorities are disproportionately 
represented in publicly funded sources or no health insurance at all (Smedley et al., 
2003). Therefore, white Americans with cancer are more likely than black Americans to 
receive optimal screening, diagnosis, and optimal cancer treatment once diagnosed.
Colorectal Cancer and Health Disparities
Colorectal cancer is of particular importance because it is the third leading cause 
of cancer-related deaths in the U.S. (ACS, 2008) and the third leading cause of cancer 
deaths among African American men and women (ACS, 2008). An estimated 7,120
deaths from CRC occurred in 2007 among African Americans (ACS, 2009). The higher 
death rates account for one-fourth of the disparity in cancer death rates between African-
American and white women and 11% of the disparity between African American and 
white men (ACS, 2007). Though overall death rates from CRC have declined since 1990, 
17
the reduction has been smaller in African Americans than in Whites (0.9% per year 
versus 1.9%) (ACS, 2007).  Chen et al. (1997) conducted a cancer survival study and 
found that blacks have a poorer colon cancer survival rate than white patients and have 
more advanced state disease at diagnosis. Though the exact causes of disparity are 
unknown, there are several factors that increase the risk of colorectal cancer including 
obesity, physical inactivity, cigarette smoking, a diet high in red or processed meat, and 
heavy alcohol consumption (ACS, 2007, p. 10).
Improved preventive care may have an impact in narrowing the colon cancer 
incidence and survival gaps in the African American population. CRC is a unique cancer 
in that screening for the disease offers the potential for primary and secondary prevention 
(Vernon, 1997). Factors that are protective against colorectal cancer include occupational 
or recreational physical activity, a diet high in fruits and vegetables, and colorectal cancer 
screening with removal of polyps (polypectomy) before they progress to cancer (ACS, 
2007). Therefore it is important to develop culturally appropriate programs for African 
American men and women so that they can engage in healthy behaviors that allow for 
prevention and early detection of colon cancer. Programs such as these will contribute to 
the reduction of racial and ethnic health disparities in the United States. 
Colorectal Cancer Screening Recommendations
The American Cancer Society, the American College of Radiology, and the U.S. 
Multi-Society Task force on Colorectal Cancer updated the CRC screening guidelines to 
distinguish between screening tests that primarily detect cancer and those that are more 
likely to detect both cancer and adenomatous polyps (ACS, 2008). The updated 
guidelines recommend men and women at average risk for CRC to begin screening at age 
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50 using one of the following preferred tests to screen for polyps and cancer: 1) flexible 
sigmoidoscopy every 5 years, 2) colonoscopy every 10 years 3) double-contrast barium 
enema every 5 years, or 4) CT colonography (virtual colonoscopy) every 5 years (ACS, 
American Cancer Society., 2008; Levin et al., 2008). The following tests are primarily 
effective at detecting cancer alone because the opportunity for prevention is limited and 
not the primary goal: 1) fecal occult blood test (FOBT) annually, and 2) Stool DNA test 
which currently has an uncertain test time interval.
Screening at an earlier age is recommended for those with a family history of 
CRC including those who have a first-degree relative (FDR) with a history of colorectal 
cancer or polyps younger than 60 years of age, two FDRs of any age with a history of 
CRC, or a family history of familial adenomatous polyposis or hereditary non-polyposis 
colon cancer (American Academy of Family Physician (Read & Kodner, 1999).  Murff et 
al. (2008) found that African American FDRs were less likely to undergo colonoscopy 
screening compared to whites with affected relatives. Additionally, in a recent study by 
Rubin et al. (2009), of 253 CRC patients only 120 (47.4%) knew that their first degree 
relatives were at increased risk for the disease. Thirty-four point eight percent (34.8%) 
believed that their FDR had the same risk of CRC as the general population, and 14.2% 
believed that their FDRs were at a lower risk than the general population. Additionally, 
Caucasian patients were significantly more likely to know of their increased family risk 
than African-American patients. Rubin et al. (2009) also reported that it remains unclear 
what role the CRC patients play in the communication of risk to FDRs.
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Colorectal Cancer and Diagnosis Disclosure
The literature on colorectal cancer diagnosis disclosure to first-degree relatives is 
sparse. However, there is analogous research that focuses on disclosure of other cancers 
and disclosure of genetic risk. These genetic risk studies are limited and mainly focus on 
late-onset disorders such as Huntington’s disease, heredity breast/ovarian cancer, 
balanced translocations, and recessive disorders such as cystic fibrosis (Forrest et al., 
2003; Julian-Reynier et al., 2000; Wagner Costalas et al., 2003). A few studies discuss 
breast and prostate cancer diagnosis disclosure as a part of a study, but the focus is not on 
the criteria individuals use to determine whether or not to reveal a diagnosis. 
Genetic Risk
Wagner Costalas et al. (2003) describe the results from a survey designed to 
assess patterns of communication within families shortly after an individual receives 
results of BRCA1 and BRCA2 (BRCA1/2) gene mutation cancer status.  The sample 
consisted of 162 women who received results from BRCA1/2 genetic testing. The authors 
were particularly interested whether there were difficulties in communicating the results 
and if the patient experienced distress with sharing the results. Using a telephone 
interview questionnaire with open-ended questioning, it was revealed that participants 
shared their results more often with their female relatives than with their male relatives. 
Those with positive BRCA1 or BRCA2 genes shared their results with 82 
(83.7%) of their relatives. Interestingly, when asked if there was a particular relative who
seemed to have difficulty understanding the test results, respondents reported that 12.4% 
of their siblings had difficulties understanding the results compared with 1.54% of adult 
children (p.15). Gender was not statistically significant in that an approximately equal 
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percentage of male (8.3%) and female (7.4%) blood relatives were reported to have had 
difficulty understanding the test results (p.15) (Wagner Costalas et al., 2003).  
The results of the Wagner Costalas et al. (2003) study revealed that individuals 
disclose their genetic test results to their at-risk relatives and they most often share their 
results with their adult sisters and daughters than with their adult brothers and sons (p. 
15).  This study did not delve further into the reasons why men were less likely to be told.  
These issues should be further explored because daughters of adult brothers and sons may 
be at risk for inheriting the gene for breast cancer and should be informed of that risk. 
Additionally, the difficulties experienced by the patients were not further explained in the 
study, indicating the need for further research in this area.
Julian-Reynier et al. (2000) conducted a cross-sectional self-administered survey, 
to determine women’s attitudes towards the family disclosure of positive breast cancer 
genetic testing results and to determine the predictive factors of the diffusion patterns 
observed.  The women in the sample attended a breast cancer genetic clinic in France. Of 
the 398 respondents, 383 had at least one living first-degree relative to inform.  Only 
8.6% of women attending cancer genetic clinics because of breast/ovarian cancer stated 
they would inform none of their living first-degree relatives. The sibling was the most 
frequently informed blood relative before children, mother, and father.  Women in the 
family were also more informed than men. 
Julian-Reynier et al. (2000) contend that family disease diagnosis disclosure of 
heredity disease areas is critical because informed patients are the key actors for 
disclosing genetic information to the relatives when a mutation has been identified in the 
family. However, the Julian-Reynier, et al. (2000) study does not further discuss the 
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impact disclosure may have on the patient or the stress that the disclosure process may 
pose on a patient. 
The Wagner Costalas et al. (2003) and the Julian-Reynier et al. (2000) studies 
only involved women in their study populations due to the mostly female breast cancer 
patient population. It is imperative that disclosure in men also be explored.  Hallowell et 
al. (2005) conducted in-depth interviews to explore the way in which information about 
BRCA1/2 testing is communicated within the families of men who undergo genetic 
testing. The sample included men (n=17), their partners (n=8) and adult children (n=4). 
They focused on cases in which the father had undergone BRCA1/2 predictive testing 
and described the process of communication within the immediate family.  It was 
revealed that male patients and their partners perceive themselves as responsible for 
disclosing information about genetic testing and genetic risks to their children. The 
parents described three different communication strategies for their disclosure to their 
children: 1) complete openness, 2) limited disclosure, and 3) total secrecy.  The adoption 
of the different strategies was influenced by children’s competence and life stage and 
pragmatic considerations (such as if the delivery of the information was to be face-to-
face). In families where cancer is currently an issue (relative recently diagnosed, treated 
or died) it may be easier for a parent to discuss and more difficult to hide from adult 
children (Hallowell et al., 2005).
None of the men in the Hallowell et al. (2005) study indicated that they did not 
want to inform their children of their cancer status, but some were unwilling to share 
information with their children until the test results were known. However, “lone parents 
may face difficulties when disclosing information about genetic testing to children and 
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may need additional support from genetic counselors/ clinicians and at-risk children may 
also require extra support” (Hallowell et al., 2005, p. 500). This study points to certain 
circumstances that may influence the ease or difficulty of disclosure. It is important to 
understand the impact of disclosure on those who have a risk based on heredity alone, not 
necessarily due to a gene mutation that predisposes them and their family members to an 
illness.
Other Cancers
Gray, Fitch, Phillips, Labrecque, and Fergus (2000) conducted separate and 
simultaneous interviews (three times) with Canadian men diagnosed with prostate cancer 
and their spouses who were referred by urologists in the Toronto area. Interviews 
consisted of open-ended questions designed to explore men’s decisions about a prostate 
cancer diagnosis disclosure and ongoing medical situations with others besides their 
spouse. Many men in the study commented that if it had been possible, they would have 
avoided telling anyone other than their spouse. The main criterion for men deciding 
whom to tell about their prostate cancer was their perception of the others’ right or need 
to know.   Especially in the case of family members, there was often a felt sense of 
obligation to inform, expressed in terms of providing information about possible genetic 
risks for other family members.  A few men in the study, especially those who were 
younger and employed, spread the news of their prostate cancer widely among friends 
and co-workers. They told men that they should pay attention to their health and get 
tested for prostate cancer.
The Gray et al. (2000) study provides important information about the decision-
making criteria that men use in prostate cancer disclosure such as the others’ right or 
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need to know. It will be beneficial for future research to understand the social support 
factors that influence the disclosure, especially the characteristics and factors that 
influence those men who share their diagnosis widely with others.
A study by Henderson, Davidson, Pennebaker, Gatchel, and Baum (2002)
documented and described disclosure patterns and attitudes among breast cancer patients. 
This study revealed some factors that may contribute to the degree to which breast cancer 
patients talk about their cancer. Though not true for all patients, most wanted to and were 
able to talk with others about their cancer. The degree of disclosure was predicted by the 
participant age in which younger subjects discussed their disease significantly more than 
older patients. Disclosure was also predicted by severity of disease, with more disclosure 
associated with greater severity of disease. Out of 270 participants, 20 reported little or 
no disease disclosure to anyone besides their spouse or doctor. Approximately one-third 
of the extremely low disclosers wanted to keep their cancer a secret, one-third found it 
difficult to discuss their cancer, and half wanted to talk to someone about their cancer.  
According to the authors, this suggests that some breast cancer patients have a desire for 
secrecy, while others may experience social constraints or barriers to discussion. Though 
this study contributes to the literature on cancer disclosure, it was a quantitative study and 
did not assess more subtle, qualitative aspects of disclosure (Henderson et al., 2002).
Hilton, Emslie, Hunt, Chapple, & Ziebland (2009) conducted a secondary analysis 
of narrative interviews of 37 young people between the ages of 18 and 34 at diagnosis to 
explore how they discussed their experience of disclosing their cancer diagnosis to 
families, friends, and wider social networks. They found that most men and women were 
open about their illness and told family, friends, and close colleagues. However, telling 
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loved ones about their diagnosis was one of the most difficult aspects of having cancer 
and patients delayed telling those they perceived to be vulnerable. Hilton et al. (2009)
found that men made connections between disclosure and their identity in a way that 
women did not, and found that men were more secretive about their diagnosis. This study 
adds to the literature on disclosure among young adults with cancer and describes gender 
differences that impact disclosure. However, this study focused on multiple cancers and 
does not take into account the levels of stigma associated with different types of cancer 
that affect disclosure or the impact that familial risk has on disclosure. 
Henderson et al. (2002) asserted that theoretical and empirical work suggests that 
inhibition of traumatic or stressful experiences is deleterious to health and well-being. 
Additionally Ballard-Reisch & Letner (2003) found that talking about cancer helps 
patients organize their thoughts and feelings and helps to make sense of their experience. 
However, Gray et al. (2000) found that there is no reason to suspect that it is 
psychologically or socially more adaptive to disclose to those in one’s social network 
than not to disclose.
When it comes to disclosing to family members with a familial or genetic risk, it 
is widely assumed that informing persons about their genetic risk or susceptibility for 
cancer is beneficial (d'Agincourt-Canning, 2001). It is asserted that obtaining information 
may encourage identified individuals to engage in cancer screening or avoid exposure to 
behavioral risk factors such as poor eating habits or a sedentary lifestyle. However, these 
assumptions are based on a medical model that views the individual as rational, 
independent, and autonomous (d'Agincourt-Canning, 2001). In fact, in a study of 368 
relatives of colorectal cancer patients, Madlensky, Esplen, Gallinger, McLaughlin, & 
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Goel (2003) found that perceived susceptibility to CRC, advice from family members, 
and exposure to public awareness information were not associated with screening.  Murff 
et al. (2008) found that African Americans with multiple affected FDRs were half as 
likely to have undergone recommended screening procedures when compared to whites, 
even after adjusting for education, annual income, and insurance status. In both groups, 
the most common reason for not participating in screening procedures was lack of 
recommendation from their health care provider. This points to the need for further 
research to discover how African American FDRs perceive the information they receive 
when a family member discloses a CRC diagnosis and how this information impacts their 
health behaviors. 
Therefore, additional research on how a patient rationalizes disclosure of 
diagnosis and the process of weighing the benefits and consequences will contribute to 
appropriate recommendations for patients. A growing area of literature known as “family 
secrets” has the potential to contribute to continued research in this area.
Family Secrets Framework
According to Brown-Smith (1998), “that which is kept secret or private has 
various meanings to different families and/or to different family members” (p. 24).
Disease disclosure can be thought of as being a type of family secret.  Little research has 
explored the criteria that people employ when they decide to reveal information deemed 
personal or intimate such as a disease diagnosis. There is a growing area of social work 
research that discusses the effects of secrets and disclosure within families. Revealing 
family secrets can have important personal and relational consequences (Vangelisti et al., 
2001). Vangelisti et al. (2001) report that keeping family secrets is often portrayed as 
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having negative consequences for individuals and popular U.S. culture discourages 
family secrets.  They contend that there is a broad spectrum of potential consequences 
that accompany the disclosure of family secrets which makes decisions about whether to 
reveal the secret complex. 
Vangelisti et al. (2001) define criteria for revealing family secrets as the 
prerequisites or standards people use to judge whether they should divulge secret 
information about their family to others. The authors reviewed preliminary ideas about 
the criteria individuals may use when they consider whether to reveal a family secret. 
They found that people may reveal secrets when: 1) the secrets threaten their own well-
being both physically and psychologically; 2) the anticipated response from a confidant is 
positive; 3) the communication context creates an opening or an opportunity for 
disclosure; 4) the impact of the disclosure on family members is positive such as 
receiving social support; and 5) when the disclosure itself brings some reward such as 
social validation.
A limitation of the definition of criteria for revealing family secrets proposed by 
Vangelisti et al. (2001) is that it is limited to secrets kept by the entire family from 
outsiders (whole family secrets). However, the findings point to the complexity involved 
in disclosing secrets. Additional research should be conducted in order to investigate if 
the criteria used are relevant to information about one’s self  kept from other family 
members and if the criteria is dependent on the type of secret, such as if the criteria is 
applicable to someone interested in disclosing a disease diagnosis to family members.  
The proposed study is innovative in that the Vangelisti et al. (2001) criteria have not been 
used to investigate a cancer diagnosis in general and a CRC diagnosis in particular. 
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However, the criteria for revealing family secrets are applicable to the current study 
because it will contextualize CRC disclosure as a secrecy issue in the literature. 
Afifi et al. (2005) conducted a study with 171 families (629 family members) to 
determine the number and type of family members who were withholding secrets from 
one another. They used a quantitative survey and followed up with an in-depth interview. 
This questionnaire design was inappropriate because many questions were left 
unanswered because there was a lack of in-depth responses. The researchers found that 
individuals refrained from revealing secrets for fear of how their family member would 
respond, which was based upon aggressive reactions to prior revelations to this person. 
Conversely, the unpredictability of a reaction was also a factor. Communication efficacy 
played a role in that people continued to conceal negative secrets from aggressive family 
members whether or not they felt they had the ability to communicate the secret. If past 
experiences were consistently negative, individuals felt as though there was no way to 
communicate the secret in such a way that it could produce a positive response and they 
felt as if they had little or no ability to affect the interaction. Potential moderators 
included age, rigidity in a family member’s values, time that a participant spent with their 
family members, and the longevity of the impact of the secret.  The participants in this 
study were largely comprised of white, middle-class families and may not be 
representative of the diversity of families in the U.S. The current study will fill this gap 
by focusing on the African American family.
The Vangelisti et al. (2001) and Afifi et al. (2005) studies are specific to secrets 
about family relationships including secrets that go against cultural norms or those that 
would be considered immoral. In addition, the actual secrets of the participants were not 
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fully described in these studies making it difficult to generalize the results of these studies 
to a patient population who may want to reveal private information such as a colorectal 
cancer disease diagnosis. 
Social Support Framework
Social support has been shown to be associated with increased cancer screening. 
However, these studies focused on general categories of support. Few studies have made 
finer distinction in the type of social support and providers of that support (Gili, Roca, 
Ferrer, Obrador, & Cabeza, 2006).
Gili, Roca, Ferrer, Obrador, & Cabeza (2006) used the concept of perceived social 
support to identify factors related to CRC screening adherence in a sample of siblings of 
CRC patients in Spain. The results found that adherents to CRC screening perceive a 
greater level of social support. However, this study did not examine the family as a 
source of support, only friends, work colleagues, and health staff.
Honda and Kagawa-Singer (2006) examined CRC screening adherence among a 
sample of Japanese Americans aged 50 and over. They found that emotional family 
support, but not the size of the networks, was indirectly related to adherence. However, 
this study was not focused on CRC patients or their family members who were at a higher 
risk for developing the disease.
Madlensky, Esplen, Gallinger, McLaughlin, & Goel (2003) examined relatives of 
CRC patients to determine whether decisions regarding CRC screening by relatives were
influenced by social interactions with family members, friends, and physicians or public 
awareness campaigns. The quantitative study focused on advice giving and 
encouragement between at-risk relatives and their families, healthcare providers, and 
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social contact. Overall encouragement to be screened from family members was 
examined at the family level. The results indicated that screeners had more affected 
relatives, were more likely to discuss CRC screening after diagnosis in the family, and 
were more often encouraged by relatives than non-screeners. Though this study provided 
insight on the screening behaviors of FDRs, this study was based in Canada and did not 
include African Americans. In addition, the study did not include details on the type of 
encouragement or support from CRC patients that influenced FDR screening. 
Kinney, Bloor, Martin, and Sandler (2005) examined the relationship between 
social networks and CRC screening among blacks and whites in North Carolina selected 
from a random sample in the general population. They examined relationships between 
both structural (number of ties and frequency of contact) and functional (emotional or 
instrumental support) aspects of social ties and utilization of colorectal cancer screening 
tests. They found that those who were most socially connected were more likely to report 
recent use of CRC screening. Neither emotional nor instrumental support was associated 
with screening behavior, suggesting that structural (number of ties and frequency of 
contact with ties) rather than functional (offering emotional or instrumental support) 
aspects of social ties may be important in influencing CRC screening behavior. This 
study points to the fact that these social support characteristics should be further explored 
using a qualitative methodology to determine if functional aspects of support are related 
to screening among FDRs of CRC survivors. 
Summary
None of the studies reviewed thus far were focused on African Americans alone, 
or were specific to patients and FDRs. In fact, the majority of the studies were conducted 
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with populations outside of the United States (Forrest et al., 2003; Gray et al., 2000; 
Hallowell et al., 2005; Honda & Kagawa-Singer, 2006; Julian-Reynier et al., 2000).
Therefore, research specific to colorectal cancer and African Americans should be further 
explored, taking into account the numerous social support and decision-making factors 
that impact CRC disclosure to family members who are at risk of developing the disease. 
This is important for developing appropriate recommendations and health promotion 
programs that result in reducing the CRC health disparity.
The current study will contribute to the literature by using a qualitative 
methodology to more fully examine the mechanisms of social support and criteria used 
during the CRC disclosure process. It will also examine disclosure from both the patient’s 
and relative’s perspective and focus exclusively on African Americans, the group with 
the highest rates of CRC in the U.S. The findings will contribute to an understanding of 
the disclosure decision-making patterns among African Americans and identify 
appropriate recommendations for disease disclosure to a first-degree relative. Ultimately,
this study will contribute to the development of culturally relevant, interventions that 
contribute to narrowing the CRC health disparity among African Americans.  
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Chapter Three
Research Methods
The purpose of this study was to explore the role of perceived social support and 
the criteria for revealing family secrets on disease disclosure among African American 
male and female colorectal cancer survivors and their family members. This study used 
the social support and family secrets frameworks to examine how family support and 
closeness to the patient impact disclosure to first-degree relatives (FDR) and how this 
disclosure influences CRC screening activities in African American families. This 
exploratory study attempted to answer the research questions: 1) What factors influence 
patients’ decisions to reveal a CRC diagnosis to family members?; 2) What decision-
making criteria do patients use to help them decide to disclose or not disclose a CRC 
diagnosis (including whether disclosure: a) threatens the patient’s well-being; b) the 
anticipated response from a confidant is positive; c) the communication context creates 
an opening as in finding an opportunity for disclosure; d) the impact of the disclosure on 
family members is positive such as receiving social support; and e) when the disclosure 
itself brings some reward such as social validation)?; 3) What roles do emotional, 
instrumental, informational, and appraisal types of social support play in a patient’s 
decision to disclose his/her diagnosis to an FDR?; 4) How do FDRs perceive the 
information they received about the patient’s diagnosis?;
5) How do diagnosed patients influence the screening behaviors of their FDRs through 
emotional support, instrumental support, informational support, and appraisal support?
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This dissertation research study was a component in a larger study conducted at 
Moffitt Cancer Center (Principal Investigator: Dr. Clement K. Gwede; USF IRB 
#106449). The qualitative sub study instrument was administered prior to the instrument 
battery of the larger study.  This two-phase study employed a qualitative research 
approach which included: 1) in-depth, face-to-face semi-structured, interviews with
patients in phase one and 2) semi-structured telephone interviews with FDRs in the 
second phase (See concept model in Appendix A).
An in-depth interview is an open-ended, discovery-oriented method (Guion, 
2001).  The goal of the interview is to deeply explore the respondent's point of view, 
feelings and perspectives (Guion, 2001). This is appropriate when there is a need to 
understand individual decision-making (Guion, 2001).  In this study, individual 
interviews were face-to-face and semi-structured: an initial set of questions were
developed to guide the researcher and ensure key topics were covered in sufficient depth 
to answer the research questions, but the researcher changed the order, added questions, 
and probed for deeper meanings, as appropriate. Face-to-face interviews were used with 
patients in this study because they typically have the highest response rates and greatest
face validity (Neuman, 2003).
Telephone interviews were conducted with FDRs of patients in this study. In a
telephone interview, the interviewer calls a respondent at home, asks questions, and 
records answers (Neuman, 2003). The telephone interview is a popular method because 
ninety-five percent (95%) of the population can be reached by telephone (Neuman, 
2003). The telephone interview is a flexible method with most of the strengths of face-to-
face interview and it is half the cost (Neuman, 2003).
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The participants for this study were patients diagnosed with and treated for 
colorectal cancer and their first degree relatives. Specific details regarding the 
participants, research design, data collection instruments, and procedures are presented in 
this chapter.
Sample
A two-phase sampling methodology was used for this study in order to reach the 
populations of interest. The primary sample frame was the cancer registry database at St. 
Joseph’s Hospital located in Tampa, Florida. The secondary sample frame was the cancer 
registry database at Moffitt Cancer Center located in Tampa, FL. The secondary sample 
frame was employed to supplement the primary sample frame in order to recruit an 
adequate number of study participants.
St. Joseph’s Hospital Cancer Institute
St. Joseph’s Hospital (SJH) is affiliated with the H. Lee Moffitt Cancer Center 
and Research Institute (HLMCC), located in Tampa, Florida, which allows SJH to further 
expand its care so that patients are receiving the most up-to-date, advanced cancer care 
available as well as access to nationally-recognized clinical trials. The affiliation 
reinforces the concept of delivering primary cancer care in their highly regarded hospital 
while tapping the expertise and resources of academic researchers to assist in the 
treatment of rare and complicated cancers (SJH, 2010).
The comprehensive cancer registry at St. Joseph’s Hospital’s Cancer Institute 
(SJHCI) includes local and national data on individuals diagnosed with cancer. The 
Cancer Registry is an integral part of SJHCI and aids the institute in education, research, 
and lifetime patient follow up. The primary function of the Cancer Registry is to provide 
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continuum data management services under the leadership and support of the Cancer 
Committee. Cancer data collection is available to the medical staff for special studies, 
audits and research. SJHCI initiated data collection for the Cancer Registry in 1976 with 
over 40,000 accumulative cases. The registry reference year was changed to 1990 for 
better control of maintaining current follow-up and treatment on over 22,000 patients. 
Lifetime follow-up for former patients is a vital component of the cancer program. The 
registry utilizes the Electronic Registry System (ERS) for collection, analysis and quality 
improvement.
Advantages. When the study began, the researcher was a HLMCC employee. As 
such, the researcher had access to the patients in the SJHCI cancer registry.  The cancer 
registry representative first gave the researcher permission to contact a patient to ensure 
that the patient met the minimum eligibility requirements. This affiliation with SJHCI 
gave the study more credibility among potential participants because his/her treating 
hospital recommended him/her for the study.
The procedures for obtaining patient contact information were simple, requiring 
contact with a cancer registry representative. As an HLMCC employee, the researcher 
had the ability to contact the cancer registry representative face-to-face or through other 
means and received a timely response.
Disadvantages. SJHCI has a significantly smaller amount of African American 
cancer patients compared to white patients.  However, given the number of African 
American patients seen for colorectal cancer in 2005-2008, the sampling frame was 
determined to be suitable for this research study. 
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H. Lee Moffitt Cancer Center
The cancer registry database at the H. Lee Moffitt Cancer Center (HLMCC) 
includes over 80,000 analytic, non-analytic, historical, and autopsy cases accessioned 
since Moffitt began accepting patients in 1986 (HLMCC, 2007). The database includes 
all patients with active cancer and/or those receiving therapy for active cancer whose care 
is managed at HLMCC.  Patients entered into the database are followed for life in order 
to determine treatment outcomes and survival (HLMCC, 2007). The HLMCC sample 
frame was determined to be appropriate because in 2006 alone, there were over 221 
patients treated for colorectal cancer at the facility.
The Moffitt Cancer Registry follows guidelines set by the Florida Department of 
Health and the American College of Surgeons (ACOS) to determine patient eligibility for 
inclusion in the Cancer Registry database. Once the case-finding process is completed, 
and a patient is determined to be an eligible case, the patient’s information is abstracted 
by a Certified Tumor Registrar (CTR). The Cancer Registry collects information on 
demographics, history of cancer, diagnosis, stage, treatment, recurrence, and survival 
(HLMCC, 2007). As a requirement of Florida statute 385.202, each patient admitted for 
the treatment of cancer is reported by HLMCC to the Florida Department of Health.
Advantages. At the time of the study, the researcher was a HLMCC employee. 
As such, the researcher had access to the patients in the registry and their treating 
physicians.  When possible, the treating physicians recommended patients for the study. 
In this case, the physician recommendation gave the study more credibility among 
potential participants given that their treating physician recommended them for the study.
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The procedures for obtaining patient contact information were simple, requiring 
contact with a cancer registry representative. As an HLMCC employee, the researcher 
had the ability to contact this person face-to-face or through other means and received a 
timely response.
Disadvantages. Historically, the racial and ethnic diversity of the patient 
population at the HLMCC has been limited, with the majority of patients being white.
Though two patients were recruited from this sample, this sampling frame did not have 
an adequate number of African American patients to answer the research questions, and 
the majority of patients were recruited from the primary source described above. 
Eligibility Criteria
The sampling plan represented a combination of the pre-determined variables and 
themes of interest: number of months/years since treatment and living FDRs. Eligible 
patients included male and female adults aged eighteen and older who had been treated 
with definitive surgery for localized or locally advanced CRC in the past five years.  
After obtaining names from the cancer registry based on the first level of eligibility, the 
following criteria had to be met: 1) patient received treatment with curative intent; 2) 
patient was six months to five years post initial definitive treatment; 3) patient had at 
least one living adult sibling or adult biological child, and 4) patient was not undergoing 
active treatment during enrollment. Those individuals outside of these guidelines were 
excluded from the study.  
Eligible FDRs were those age 18 years and older, with no personal history of 
colorectal cancer. 
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Recruiting Participants
Patients. A list of potential patient participants including contact information was 
generated from the sampling frames described above. The director of the SJHCI sent an 
introductory letter to each potential participant using SJHCI letterhead. This letter 
explained that researchers from HLMCC would contact them about participating in a 
research study.  Approximately two weeks later, the researcher sent a letter with specific
details about study participation.  Included in the letter was a telephone number for 
interested survivors to call for additional information and to enroll in the study.  Those 
who did not call back to decline participation were contacted by the researcher to 
determine interest and potential eligibility. Those who declined to participate were not 
contacted again. The researcher documented participation rates including ineligibility and 
refusal for each potential participant by entering the information into a Microsoft Excel 
file stored on a secure database. 
Potential participants were contacted by the means they indicated as preferred 
(physical mail, electronic mail, & telephone). During this contact, potential participants 
were screened for a second level of eligibility (information related to the date of last 
diagnosis and time of last treatment). The men and women who met the eligibility 
requirements and agreed to participate were contacted to schedule a date and time to 
participate in the in-depth face-to-face interviews at a community location of their choice 
(e.g., residence, library, local restaurant, bookstore etc.). Participants received a reminder 
phone call or letter prior to the scheduled interview time.  Prior to participation in the 
study, participants were asked to provide informed consent for the study and gave 
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permission to take notes and record the interview. At the end of the interview the 
handwritten notes were used to validate responses. 
First-degree relatives. As part of the eligibility criteria, patients recommended 
one or more first-degree relatives aged 18 and over to complete a telephone interview. 
Those relatives were contacted by telephone to determine eligibility. Those relatives who 
met the eligibility requirements and agreed to participate were scheduled for a telephone 
interview. Prior to the interview, the researcher mailed an informed consent document 
along with a self-addressed postage paid envelope that was to be signed and returned. If 
an informed consent document was not returned by the time of the scheduled telephone 
interview, the researcher obtained oral consent from the participant. This approach 
allowed for the flexible scheduling of the telephone interviews given that many FDRs 
preferred to schedule the interview prior to the researcher receiving the signed informed 
consent. Participants received a reminder phone call and letter sent through the U.S. mail 
prior to the interview.
Token of Appreciation
Patients and FDRs were given a $30 money order to thank them for participating 
in the study. Once their signed informed consent document was received, a money order 
and a letter of appreciation were mailed to the participant. 
Selection and Sample Size
Sandelowski (1995) noted that a sample size of ten may be adequate for certain 
kinds of homogeneous or critical case sampling and Guest, Bunce, and Johnson (2006)
proposed that a sample of twelve may be adequate. Qualitative research typically 
involves purposeful non-probability sampling aimed to develop a deep understanding 
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through information-rich cases (Sandelowski, 1995). Although not statistically 
representative, it is informationally representative in that data were obtained from persons 
who “have direct and personal knowledge of some event that they are able and willing to 
communicate to others” (Sandelowski, 1995, p. 180).
Using a purposive non-probability sampling strategy, the researcher conducted 
sixteen individual interviews with CRC patients (4 men and 12 women) who were six 
months to five years post-treatment for a response rate of 39%. Each patient was asked to 
refer one or more FDRs to complete a telephone interview. From this recruitment, sixteen 
FDRs (3 men and 13 women) completed telephone interviews for the study for a response 
rate of 80%. The total sample size for patients and FDRs in this study was 32 participants 
Figure 1 shows total eligible and enrolled participants and their reasons for non-
participation.
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Instrument
Face-to-face and telephone interview protocol. The investigator applied an 
adapted version of the social support and family secrets frameworks to structure the 
drafts of face-to-face and telephone interview guides. According to House (1981) social 
support is the functional content of relationships which can be categorized along four 
basic types of support 1) emotional support; 2) instrumental support; 3) informational 
support; and 4) appraisal support. According to the Vangelisti et al. (2001) family secret 
framework, people may reveal secrets when: 1) the secrets threaten their own well-being 
both physical and psychological; 2) the anticipated response from a confidant is positive; 
3) the communication context creates an opening or an opportunity for disclosure; 4) the 
impact of the disclosure on family members is positive such as receiving social support; 
and 5) when the disclosure itself brings some reward such as social validation. Tables 1
and 2 show how constructs from each framework were used by the researcher to develop 
the questions used in the drafts of the interview guides. 
In order to provide the evidence for the trustworthiness of the final instrument, a 
consensus process was employed to finalize the instrument drafts (Sandelowski, 1995). A 
panel of experts (investigator’s dissertation committee) independently arranged all survey 
items developed by the investigator into theoretically sound categories. This sorting 
exercise aimed to ensure that each interview question clearly represented the intended 
theoretical construct. After consensus was reached, the final instruments were pre tested
with four volunteers (one male and one female CRC patient and one male and one female 
FDR of a CRC patient). Participants involved in the pre testing were not enrolled in the 
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actual study and the information they provided was not analyzed for the results of this 
study.
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The guides were developed based on a literature review of previous studies on 
disease diagnosis disclosure and with studies that incorporated social support and family 
secret frameworks, as well as the expertise of advisors and mentors. Based on data from 
the pilot test and additional feedback from advisors and mentors, the qualitative interview 
guides were revised and modified. See Appendix B for final interview guides. 
The semi-structured in-depth face-to-face interviews with patients lasted 20-30
minutes and the semi-structured telephone interviews with FDRs lasted 15-30 minutes.   
Data Management
Data were collected using in-depth, in person interviews with a semi-structured 
interview protocol. The interviews were recorded using a digital voice recorder that was 
saved as an audio file.  To ensure accurate recordings of the participant’s responses, all
equipment was tested immediately before each interview. Back-up equipment was also 
present at each interview. The saved audio file was sent to a professional transcriber in 
order to prepare the written transcripts. All data were stored in the researcher’s password 
secured computer and locked file cabinets.  Only personnel working with the study had 
access to the computer and file cabinets and all persons working with the study were 
required to sign confidentiality statements.  Informed consent forms were also stored in a 
locked file cabinet, in a separate file, away from interview transcripts. 
Data Analysis
The final verbatim transcriptions were formatted into an electronic Microsoft 
Word® document.  Interview transcripts were analyzed using Atlas.ti® software. Once an 
interview was completed, the electronic data file was sent to a professional transcriber for 
transcription. The data analysis began as soon as the transcripts were returned to the 
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researcher. The researcher employed the constant comparative method of qualitative 
analysis developed by Glaser (1965). This method consisted of: 1) comparing cases 
applicable to each content category, 2) integrating categories, and 3) delimiting the 
theory. 
The researcher reviewed the data and developed a priori codes that were specific 
and tied to the research questions and theoretical framework. While coding a case for a 
category, the researcher compared it with the previous cases coded in the same category 
(Glaser, 1965). For example, as the researcher coded a case in which a patient expected 
instrumental support from an FDR, she then compared this case with other cases 
previously coded in the same category before further coding (Glaser, 1965). The constant 
comparison of the interview text provided common themes regarding disease disclosure 
to first-degree relatives based on the individual various types of social support and the 
criteria used to reveal secrets. During this process, a codebook was developed to 
operationalize and define each of the themes.
After review of the first set of common themes and the development of the initial 
codebook, the researcher employed a double coding method to be used for the final two 
steps of the constant comparative method. Half of the patient transcripts and half of the 
FDR transcripts were randomly selected to be coded by a second coder. The second coder 
for the patient transcripts holds a Master of Public Health degree and is a former research 
assistant for the parent study. The second coder for the FDR transcripts holds a Master of 
Public Health degree and is a current doctoral student at a college of public health. Both 
coders are experienced in qualitative research coding.
The main focus of the axial coding was to examine the initial codes and determine the
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causes and consequences, strategies and process that cluster together while identifying 
sub-themes (Neuman, 2003). This process helped the researcher determine which themes 
to discard and which themes to examine further (Neuman, 2003). The secondary coders 
assisted with this process. During this process, the codebook was revised in order to 
update the code categories from the first open coding pass.  The dialogue between the 
researcher and second coder helped to inform the revised codebook.  This was especially 
useful in areas where the codes were initially too broad. For example, an initial code of 
“informational support” was refined into the sub-code of “informational support for 
familial risk.”
Finally, delimiting the theory, also known as selective coding was used as the 
final coding step. As the theory developed, this step reduced the data findings. Using the 
updated codebook, the researcher and secondary coders looked selectively for cases that 
illustrated themes and made comparisons and contrasts after all of the data collection was 
complete (Neuman, 2003). This allowed for coding according to the boundaries of the 
researcher’s theory (Glaser, 1965).
Use of Atlas.ti® Software
Data management and analysis were supported by the use of Atlas.ti v6, 
qualitative data analysis software.  Creswell (2007) describes Atlas.ti as a PC, Windows-
based program that enables researchers to organize their text, graphic, audio, and visual 
data files into a project file called a Hermeunetic Unit (HU).  An HU can also be used to 
organize coding, memos, and findings associated with these files.  In addition, Atlas.ti 
also has search features and query tools that allow the researcher to rapidly search, 
retrieve, and browse all data segments and notes relevant to an idea (Creswell, 2007).
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Patient and FDR Analysis. For this study, two HUs were created:  one HU was 
created for patients and the other for first-degree relatives.  The codebook and transcripts 
were uploaded to their corresponding Atlas.ti HUs in order to manage and organize the 
data.   After the hand-coding of each transcript was complete and agreement was reached 
between the researcher and secondary coders, all coders were responsible for inserting 
their information into their respective HU.  In order to do this, Atlas.ti was used to select 
sections in the transcript text and assign codes via a code list comprised of the previously 
uploaded codebook.  After this process was complete, an output file was created from 
each individual HU.  These outputs contained the quotations and codes for each 
participant and can be exported to SPSS, HTML, XML, and CSV.  The outputs can also 
be saved as printable RTF files that can be opened with Microsoft Word.  These outputs 
were analyzed to complete the patient and FDR results section.
Family Group Comparison. In order to compare the responses of the patients 
with two or more family members who participated, the Family Manager Tool within 
Atlas.ti was used.  The Family Manager allows the researcher to categorize each 
transcript into groups based on the intentions of the analysis.  For this study, the Family 
Manager was used in the first-degree relative HU to place relatives of a given patient 
together.  For example, the patient with the ID ‘PAT 555’ has two relatives – a sister 
(FDR 556) and a son (FDR 557).  The two relatives were placed in the same group given 
the label ‘PAT 555.’  The researcher is then able to export a file that contains the 
quotations for a given family organized by participant ID and codes.  The Family 
Manager Tool was not used in the patient HU.  Instead, a file for each patient containing 
both codes and quotations was exported and printed discretely.  This enabled the 
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researcher to compare each patient output juxtaposed to its corresponding first-degree 
relative output containing both codes and quotations for all first-degree relatives within 
that family.  These two outputs were analyzed and used to complete the family group 
comparison in the results section.
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Chapter Four
Results
This chapter presents the results of the data analysis. As explained in Chapters I 
and II, the Family Secrets Framework and the Social Support Framework serve as the 
guiding theoretical frameworks to understand the information collected in the study. The 
analysis was conducted with the goal of answering the research questions for this study:
1) What factors influence patients’ decisions to reveal a CRC diagnosis to family 
members?
2) What decision-making criteria do patients use to help them decide to disclose 
or not disclose a CRC diagnosis; including a) whether disclosure threatens the 
patient’s well-being; b) the anticipated response from a confidant is positive;
c) the communication context creates an opening as in finding an opportunity for 
disclosure; d) the impact of the disclosure on family members is positive such as 
receiving social support; e) when the disclosure itself brings some reward such as 
social validation.
3) What roles do emotional, instrumental, informational, and appraisal types of 
social support play in a patient’s decision to disclose his/her diagnosis to an FDR? 
4) How do FDRs perceive the information they received about the patient’s 
diagnosis?
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5) How do diagnosed patients influence the screening behaviors of their FDRs 
through emotional support, instrumental support, informational support, and 
appraisal support?
Data was obtained through face-to-face semi-structured in-depth interviews with 
patients, and telephone interviews with first-degree relatives.  Transcripts of the 
interviews were analyzed in two ways: first by emerging themes that became evident by 
topic area and second by the theoretical frameworks used to inform the design of the 
study. Data were analyzed using the ATLAS.ti 6.0 software.  In addition to themes that 
emerged from the analyses, quotations are provided to illustrate the perspective of the 
interviewed participant.  
The results are presented in three sections. Section I describes the patient sample 
and reports the qualitative results from the patient interviews.  Section II describes the 
first-degree relative sample and reports the qualitative results of the first-degree relative 
interviews. Section III is an analysis of the five families in the study (those patients who 
had two or more family members who participated in the study). This analysis is a side-
by-side comparison of the patient responses and the related FDR questions.  A summary 
of key findings concludes the chapter.
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Section I: Patients
Age, marital status, and health insurance. The patient sample consisted of 16 
adults: 4 men and 12 women who were diagnosed with colorectal cancer within the past 5 
years (2004-2009). Ages of the participants in the total patient sample ranged from 27-80
years, with a mean age of 63 and a median age of 64. With regard to marital status, 
approximately 50% of the total sample reported being married, 12.5% were divorced, 
25% were widowed, 6.3% were separated and another 6.3% had never been married (See 
Table 3).
Approximately 87.5% of participants indicated they had health insurance, with 
12.5% indicating they had none. More than half (56.3%) reported participation in the 
Medicare program, 31.3% had private health insurance.
Social economic status. In examining the social economic status (SES) of the 
patient participants, including education, employment status, and annual household 
income, the majority of the participants had at least a high school education (Table 4). 
One person preferred not to answer the question about education, four of the participants
were college graduates, two had some college or technical school, five were high school 
graduates, two completed some high school, and another two completed some elementary 
school. Half of the patients were retired, five were employed for wages, one was out of 
work for more than one year, another person was out of work for less than one year, and 
one was unable to work. 
Participants’ annual household income ranged from less than $10,000 per year to 
greater than 100,000. Four participants reported incomes of less than $10,000, five 
reported making $10,000-$25,000, two reported incomes of $25,001-$35,000, one 
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indicated an annual income of $35,001-$50,000, two reported incomes of $50,001-
$75,000, and one participant reported making over $100,000. One participant preferred 
not to answer the question about income.
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Table 3: Sex, Age Marital Status, and Health Insurance (Patients) 
(N=16)
Variable N %
Sex
Male 4 25
Female 12 75
Age
20-29 1 6.3
30-39 0 0
40-49 1 6.3
50-59 4 25
60-69 5 31.3
70-79 3 18.8
80-89 2 12.5
Marital Status
Married 8 50
Divorced 2 12.5
Widowed 4 25
Separated 1 6.3
Never married 1 6.3
Health Insurance
Yes 14 87.5
No 2 12.5
Health Insurance Type
Medicare 9 56.3
Private 5 31.3
N/A 2 12.5
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Table 4: Education, Employment Status, & Annual Household Income (Patients)
(N=16)
Variable N %
Education Completed
Elementary school 2 12.5
Some high school 2 12.5
High school graduate 5 31.2
Some college or tech school 2 12.5
College graduate 4 25
Prefer not to answer 1 6.3
Employment Status
Employed for wages 5 31.3
Out of work for more than one year 1 6.3
Out of work for less than one year 1 6.3
Retired 8 50
Unable to Work 1 6.3
Annual Household Income
Less than $10,000 4 25
$10,000-$25,000 5 31.3
$25,001-$35,000 2 12.5
$35,001-$50,000 1 6.3
$50,001-$75,000 2 12.5
$100,001 or more 1 6.3
Prefer not to answer 1 6.3
56
In-Depth Interviews
Semi-structured in-depth interviews were conducted from May 2009-August 
2009. The interviews were conducted with the use of an interview guide, which included 
a list of questions grouped by topic and domain. Interviews were conducted with a 
preformulated interview guide, but answers to those questions were allowed to be fully 
expanded at the discretion of the interviewer and interviewee, and could be enhanced by 
probes.
All sixteen of the interviews were completed face-to-face. Fourteen were 
conducted at the homes of the patients, one was conducted at a local restaurant, and one 
was conducted at a local hospital. Each interview lasted approximately 20-30 minutes.
Patient Individual Interview Findings
General colorectal cancer diagnosis experience. The first part of the interview 
focused on the patient’s experience with learning of his/her diagnosis.  In answer to the 
first question, “Can you think back to when you were first diagnosed with Colorectal 
Cancer and tell me about your experience,” most participants answered in the context of 
when they first experienced symptoms that caused them to seek medical attention. 
Examples of the responses are below:
Well I guess I was a bit prepared for the diagnosis because I started having, I went 
to the doctor with symptoms and I had been online, just kind of looking up the 
symptoms, so there was kind of red flags all over the place in terms of you know 
what those symptoms occurring, you that if it’s cancer that was said to me in 
advance. (51 year old woman)
I was telling her one day that when I drank water, you know my stomach hurt. 
She said well, why don’t you go have a colonoscopy done? So I’m thinking okay, 
well this ain’t going to hurt anything. (59 year old male)
So in the beginning, I saw when I cleaned myself and I saw the blood, of course I 
panicked, of course, and called Dr. XXX right away. I had constipation 
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constantly, you know but that was the first time I’d seen the blood, so then I said 
“Uh-oh, that’s not good! (89 year old female)
Experiences of faith and spirituality were present among other participants and 
were included as a major part of their diagnosis experience:
So I struggled and prayed, and struggled and prayed. (54 year old female)
The only thing I can do myself is pray, and hope for the Lord’s favor, because he 
is a good God. He will take care of you. (63 year old female)
…my daughter is a strong believer also, so she was telling my husband that, 
“Don’t worry, God has this all in his hands.” And you know, and they prayed 
about it, and we prayed about it, and one of my daughter's boyfriends, he prayed. 
He’s a minister. He prayed. He came in the hospital and prayed with us, and we 
read scriptures, and the normal stuff. (65 year old female)
The next question asked the patient, “What were the first three things that came to 
mind when you first learned about your diagnosis?” The majority of patients focused on 
one major thing that came to mind.  Two patients talked about the children that were in 
their care and about making provisions for them before beginning treatment.  Another 
patient was worried about whether the cancer had spread. The topics of death and dying 
were mentioned quite frequently. Some patient thoughts included: 
I did cry, real hard, and I wanted to go home right then because I said if I’m going 
to die, I want to die at home where my husband died at. (54 year old female)
The first thing come to my mind, tell the doctor to go out of the room so I can 
deal with my oncoming death. (48 year old female)
But, you know, that was my worst day, and all the day long all I could think of 
was, you know, I’m not going to see my kids have children, you know, I’m not 
going to live, all the negative stuff. (54 year old female)
In addition to the topic of death, patients expressed a strong desire to pray and to 
use their faith and spirituality to deal with the challenging road ahead. Patients did not 
mention religion or a belief in a particular denomination of Christianity. Though some 
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patients referred to a pastor, most expressions of faith and spirituality were general and 
focused on having a relationship with a higher power.
It kind of upset me a little bit, but I learned to pray, to deal with it, and I talked to 
my pastor and my pastor kept coming out there praying for me. (54 year old 
female)
First, pray. Prayer came to my mind immediately at a Stage 4. In fact, even before 
Stage 4, prayer came to my mind every day of my life. (48 year old female)
So I just started talking to the Lord and after that really, I really didn’t have time
for anything to come to mind… (64 year old female)
Disclosure experience. After allowing the patients to get comfortable talking 
about their diagnosis experience, the next part of the interview focused on the patients’ 
experiences with disclosing their colorectal diagnosis with their family members. Patients 
were asked which first-degree relatives they decided to tell, the reason for telling, and the 
results of telling. Patients reported that they disclosed their diagnosis to their spouses and 
a range of FDRs including parents, children, and siblings. Many also told second-degree 
relatives (including aunts, uncles, nieces, nephews, and cousins) along with co-workers 
and friends. A few patients were unable to tell family members prior to surgery, due to 
the lack of a definitive diagnosis until surgery. In these cases, the family members found 
out about the diagnosis at the same time as the patient:
We all found out exactly about the colorectal cancer together from the doctor 
when they did the surgery. (80 year old female)
When they admitted me, my other daughter came to see what was going on with 
me, and that’s when he (the physician) got a chance to talk to her. (65 year old 
female)
Because, when I found out myself and I was talking with my husband and the 
doctors, we asked a lot of questions, and some of my children were there, my 
daughters were there. (60 year old female)
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There was not a patient interviewed who indicated that he/she did not inform at 
least one family member about their colorectal cancer diagnosis. However, two patients 
admitted that they delayed telling certain family members:
Yeah, my daughter, my son, my husband, my sons that’s here because I have a lot 
out of town and all over the world… I didn’t tell all of them right away because it 
wasn’t time, and I wasn’t in no position. (65 year old female)
I really didn’t discuss it with him until I went to see my oncologist, you know Dr. 
XXX, the surgeon, to really know what was what. And I really didn’t know 
nothing until I actually had the surgery and they did the biopsy to see that it 
spread… And then that’s when I really got into details and told my mom, my 
family. (63 year old female)
Patient responses to the question, “What was the decision of who to tell like for 
you?” focused on the ease or difficulty associated with disclosing the news to family 
members. Eleven (n=11) said that it was easy to disclose and three (n=3) admitted that it 
was difficult to disclose. The other two patients said that one particular family member 
told the others on their behalf and there was no need to personally disclose to any other
family member.
Some of the reasons patients had for saying that it was easy to disclose are 
reported below:
No, no. It wasn’t hard, no. I guess it would have been if she had not been a doctor, 
you know. (89 year old female)
No, it wasn’t hard. I just spoke out, told them what was going on and everything. 
(70 year old male)
It was pretty easy. I told them. Well, if I died they knew, if I lived, then they 
understand me. (60 year old female)
For some patients, the decision to tell was described as difficult; however, patients 
felt that it was important to tell family members because they needed to know: 
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Yeah, so it was very-that was very overwhelming, and then having to try to 
communicate, like I talked to my mother, you know, just trying to communicate 
the, you know, the extent of what they are saying, and you know, so that’s when it 
really got scary for me… (51 year old female)
Well, it wasn’t easy for me to tell. I just did it. You know, it’s just something that 
had to be done, you know. (54 year old female)
Well, I feel like if you’ve got children, no matter what the situation is, they need 
to know. You know, that’s something you don’t hold back, you know. So, I went 
over and told them, so they was, you know. (48 year old female)
Other patients considered the potential negative consequences of not disclosing as a 
reason for telling family members about their diagnosis:
Because they going to find out anyway. If I don’t tell them, and I go down, they 
still going to find out…But if you lie, then I’ve got to go all back over this thing, 
and straighten it out and all.  (76 year old male)
Let them know because you don’t know, maybe you wait a little bit too late and 
you know someone might not be taking it good, so you just wind up getting lost if 
you don’t do it. (75 year old female)
Besides telling family members because they were in frequent contact with them, 
most patients said that the major reason for disclosure was to make their first-degree 
relatives aware of the FDRs’ risk for the disease:
You cannot hide it from them, and if the truth of the history, now I’m the first one 
with a colorectal history in my family. If you hide it from them, it is not part of 
the success plan in the future; it is a part of your family now. And you want to be 
able to watch out for it, you want that memory to be at my mother’s age, in her 
forties, she was diagnosed with a stage 4 colorectal cancer, so that if there is any 
symptoms in the future, whether they think it’s just a little pain, and even on their 
birthday, early detection is a way that I teach those children. (48 year old female)
Because I wanted them to get tested and wanted to make sure that everybody in 
the family, you know, know whether it’s cancer in the family because my father 
died of cancer about ten years ago, and so I wanted everybody to get tested and 
everybody to take care of their own selves on that side because my father passed 
from cancer. (66 year old male)
…because one of the things that I stumbled across while I was researching online 
was some statistics on African Americans and the fact that they tend to present 
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well advanced, and so some of the recommendations were even African 
Americans are screened, you know, up to ten years earlier than 50, and so I wasn’t 
50 at the time, and so, and I was reading where your siblings, everything, need to 
be screened within 10 years of your age that you were diagnosed… (51 year old 
female)
In response to the question, “How did it go when you told him/her?” patients said
they considered their family members’ feelings and minimized the seriousness of 
colorectal cancer as much as possible in an attempt to reduce the family members’ 
concern. 
So that wasn’t-so then, when I did go, I did find out, and I said, “Dr. XXX said he 
thinks he saw something there and we’ve got to take care of it right away,” you 
know and so, you know I tried to put it as easy as if it’s no big deal, you know. 
(89 year old female)
Well, just in case if I died or something, you know they would know what I died 
with, you know. That if I had to take treatment, they would know that I had to 
take treatments, so they would understand, I don’t want them worrying about it. 
(60 year old female)
But it was important to tell them as soon as the anger, the first couple of days, was 
set into reality. It was important to draw them near and tell them, “It’s serious. 
But we’re okay… I decided to minimize cancer word from the beginning. (48 
year old female)
Communication context. The next part of the interview attempted to understand
the communication context of the disclosure. The patients were asked to describe when 
they felt it was an appropriate time to reveal their diagnosis and the setting of the 
disclosure. This was done to understand when the patients felt there was an appropriate 
opportunity for disclosure. Five (n=5) patients told their family members about their 
diagnosis over the telephone. Ten (n=10) patients told family members face-to-face. One 
patient said that she told some family members face-to-face and others over the phone. 
Some responses from those who told their relatives over the telephone are below:  
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I gave a call to my daughter and she lives in Dallas, and I told her what he had 
found. (89 year old female)
Just me and my brother. Yeah, I told him about it. I told him I said well, when I 
found out about it I just called and told him. I said you know, I got cancer, I’ve 
got to have an operation. (59 year old male)
I think I called my mom that, later that, yeah, I think I called her, because she was 
working. I think I called her later on in the evening and I told her. I told my 
mother over the phone. I called my sisters. (51 year old female)
The same patient, a 51 year old female, explained why it was easier to disclose over the 
phone:
Just, just, yeah, but it is different when you are actually looking at the person, you 
know, and you just kind of see them just, you know, look all blank trying to 
absorb the information, so I guess in some ways it probably was a little easier to 
do it over the phone, because then you, there is that little bit of a, that distance of 
while they are absorbing it mostly, in fact I think, yeah, probably it’s a little 
easier. I told my dad over the phone.
Many patients explained that they told family members face-to-face. However, 
some patients told family members individually while other patients told their family 
members in groups.   Those who told their family members in groups explained the 
experience this way:
We was at my brother’s funeral home. I mean, you know, and so I told them 
while we was at that meeting. That’s all. We have, we be together all the time. 
Like I said, my family be together all the time. (66 year old male)
When the doctor told me, the day he told me. They just came over and I just told 
them all. (75 year old female)
Those who told family members individually explained how they told.
I told my husband when I came home. Did I go, I went to see my daughter, and 
then I told our son and daughter-in-law, I told them in person. (51 year old 
female)
No, it’s maybe one by one because that’s the way they did; they didn’t come all at 
one time. Like I tell this one when they come over and the next one I tell her like 
that. That’s what I did. (76 year old male)
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Similar to the section on disclosure experience, late diagnosis of colorectal cancer 
appeared to impact the communication context causing patients to explain their diagnosis 
to their family members after they started treatment or while in the hospital.
I told them right after the surgery. I didn’t know I had cancer. (54 year old 
female)
When I came out of recovery … I told them because they told me what they took 
out, so they was all there. I told them. (60 year old female)
And so, they came to the hospital. We had our own private time to talk about it. 
Nobody imposed upon that time. (48 year old female)
Expectations and Reality of Disclosure. This portion of the interview focused 
on how the patients felt after revealing their diagnosis and what they expected from 
telling their family members about their diagnosis. Most of the patients said that they felt 
relief.  Responses to the question about how they felt after revealing their diagnosis 
included:
I guess relief would be a good word. (51 year old female)
I felt relief in telling her, yes, because I figure, I figure she’s going to be here 
anyway, you know. ((laughs)) And she’s going to talk to the doctors, and you 
know, and she did, yeah. (89 year old female)
I felt relieved. I felt a burden was off my shoulders, you know what I mean? (76 
year old male)
One patient expressed that she felt uninformed:
I just wanted to know more information, where it’s going to be because they was 
acting like it wasn’t real serious and then when it’s like your mom had it (also) so 
it IS serious. So, it was like I stayed in that stage for a while. (27 year old female)
A couple of patients felt the need to pray after disclosing their diagnosis:
So I learned to pray, to read my Bible, and my pastor came for three days in a row 
and prayed, read the Bible, had prayer meetings, until I got to be all right. (54 year 
old female)
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Well, you know what, I was just peaceful when I told them because when I told 
them I had cancer, he told me I had cancer, I was like well, you know, and I 
prayed about it, so I was peaceful with what I had to do. Either way, I was at 
peace. (59 year old male)
When you’re facing a crisis, sometimes it’s not about this or the world is saying, 
or who knows what, but sometimes we just have to get in touch with the Lord. (65 
year old female)
Patients were also asked how they expected their family members to respond to 
the news of a colorectal cancer diagnosis. Though patients said they prayed after 
disclosing their diagnosis, only one patient said that he expected prayer.
Like I told somebody, it’s like when you get sick, all prayers help, as far as I am 
concerned. I want people to pray for me, you know, because I just don’t want to 
have to go through that by myself. (59 year old male)
Most patients expected other forms of emotional support, the expectation that their loved 
ones would provide empathy, love, trust, and show concern. 
I didn’t expect anything else, except to be here and be with me at least a week or 
two, you know, after. Of course, if she hadn’t been here, my granddaughter would 
have been here. (89 year old female)
I expected they was going to come visiting, you know, see about me, which they 
did. (70 year old male)
I expect them to take it and, take it and be strong with it, you know what I mean? 
And be strong with me. Because I needed their strength as much as they needed 
my strength. So I told them, you know. (76 year old male)
Patients were asked to describe what FDRs actually did for the patient after 
learning that the patient needed treatment for colorectal cancer. Patients expressed a 
range of types of support including appraisal, emotional, informational and instrumental 
support. Reports of appraisal support or receiving information for self evaluation, 
constructive feedback, affirmation (a positive statement or judgment), and social 
comparison support are below:
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They was just saying it’s something that God planned. You know, it’s something 
like it’s out of your control, you know? (54 year old female)
Well, daddy-they just called me and said Daddy, we’re going to beat it because 
you caught it in time. You didn’t wait until it spread. So, my wife and my 
children, they just went on to war with it, you know. (76 year old male)
Patients also reported that they received emotional support including love, trust, and care:
I think for them-for all of us it was just a sense that, you know, we could kind of 
be here and go through it together, because I would have been probably really 
scared up there by myself, and you know, even my husband and my daughter and 
her kids were there, but you know, you have your mama ((laughs)). (51 year old 
female)
…she was with me the whole time. Every day I was there. She worked but she 
just, afterwards she came there, at night she stayed there, and so I’m so grateful 
after that. (59 year old male)
Oh, they was there the night I went up to the surgery and up until I came home. 
They go home and rest, because they got kids, so they’d go home and they’d rest, 
and they’d come right back. (54 year old female)
Informational support in the form of providing advice and suggestions that a 
person can use to address problems was described by patients. One patient who was 
diagnosed with cancer at an unusually young age described some advice given to her by a 
family member:
So my Auntie, she’s like you need to talk to a counselor ((laughs)). So she had 
me, she called the counselor for me, and she was like you need to talk to the 
counselor about this situation and that way you get everything out. And you 
know, supportive, “You should not be scared, and everything’s going to be okay.” 
(27 year old female)
Another patient also described some of the advice she received from family members:
Well, when my daughter came I had told her that I had cancer. She said mom, 
don’t worry about it because God still is good, you know, and he’s not going to 
take you yet. (54 year old female)
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Patients said that FDRs displayed instrumental support in the form of providing 
tangible aid such as cooking, cleaning, and transportation more than any other type of 
support.
My mom helped me a lot, in the worst months. You know, she cooked for me 
because I couldn’t really move around as much, but my mom, at the age 70 
almost; she cooked for me and everything. And my daughter would come over or 
I would go out there and stay, but I had a lot of support actually. (63 year old 
female)
Take out the trash, more so than what they used to do. I didn’t have to say, “Take 
it out.” You know, clean up, pick up behind themselves. I didn’t have to do any of 
that kind of stuff. (54 year old female)
They kept cooking the food to see, to eat for me. And they support me, and read 
the Bible to me. And they support me, they clean up. They support me any kind of 
way that I needed them there, they did. And so I’m appreciative for those two 
little girls for that. (48 year old female)
Patients were asked how their family had responded to them since their treatment 
ended.  Patients explained that their FDRs continue to provide emotional support in the 
form of showing concern through phone calls and checking up on their health.
Well, they all keep asking me how I feel, are you feeling sick or anything. I said 
no, I feel normal. Every now and then I get irritated with my, you know, the 
feeling. (70 year old male)
Good. Yeah. They call me every morning. My daughters call, and my sons called 
me, you know. It’s more like a closer thing. It’s not like “I forgot.” They call. (76 
year old male)
Well, good, and they come around, they come around a lot. As always, they 
always come around a lot. And every time I see my sons, “Oh, mom, how are you
doing, mama?” (65 year old female)
Another patient said that she continued to get instrumental support from their family 
members:
My daughter, my sons takes me to work and my daughters pick me up…I still 
work on a regular basis… (64 year old female)
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Patients also reported that their family members reverted to treating them “back to 
normal” or as if they were never ill:
Fine. Hmm, well, they, I ((pause)) I don’t know why I guess I don’t expect you 
know for them to do for me, especially things that I can do for myself. (64 year 
old female)
Oh back, I’d say, back to the same, you know. You aren’t a boy. Well, I don’t 
know if you know how boys are, but oh my goodness, oh! They are back the 
same, back to the same. It’s like mama has never been sick before. (54 year old 
female)
Most of the patients in this study were positive about their decisions to share their 
diagnosis with their family:
I feel good about it… Because, I mean, it’s nothing really to hide, you know. 
There’s nothing really to hold back or hide with, you know, when you got cancer, 
you know, a lot of people do, but I don’t feel like that, you know, and my family 
don’t feel like that. They support me, you know. (63 year old female)
Yeah, I’m happy, I’m happy I told. Yes I am. I’m happy about it… I don’t know, 
you know, I don’t know, if it went by why should it be such, why would I want to 
keep it so secret? Why? (75 year old female)
Yes, I did the right thing… I did the right thing… Because if you are going to be a 
family, you don’t hide. You share. The good, the bad, you know. You share. (76 
year old male)
Effects of disclosure. An important goal of the patient interview was to 
understand the effect of the patient’s diagnosis on his/her family members. Patients were 
asked the question, what type of effect do you think disclosing your colorectal cancer 
diagnosis has had on your relatives? Many patients felt that that by sharing their 
diagnosis, family members now have more awareness and understanding about colorectal 
cancer. For example, patients said:
Well, I mean, I definitely feel like they are all aware that, you know that they are 
aware of colon cancer. And I mean I think, you know we were pretty young when 
my grandfather had Colon Cancer, but you know they are all aware, they are 
committed to getting regular checks, you know getting their colonoscopies, and 
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my daughter, she is like calling me when she gets to that, when she reaches that 
ten year mark. (51 year old female)
I think it just kind of created awareness. And then we’ve been kind of making 
sure that we share our health information anyway because we found that we kind 
of got these, you know different things that us tend to start, we’re seeing it, it’s 
running through the family, you know. (65 year old female)
I really think that that hurt us. We weren’t exercising like I should have been, you 
know and things like that. But now, you know, they are physical. They like to go 
out and do things, you know, because most of them they just sit around and watch 
a game or something like that. But they like outside stuff now. They like to go 
outdoors and do things. (54 year old female)
Patients also felt that going through colorectal cancer treatment made them 
become even closer to their family:
You know, I guess the bonding that happens when you kind of go through 
something like that. (51 year old female)
It’s like-we are strong. (76 year old male)
I think it pulled us closer together, you know, that to think that you’re too busy, 
where I was saying earlier, you’re too busy to eat lunch together. Everybody’s 
going to work. Everybody going to work, and everybody’s too busy. So I think it 
had an affect on her. How important is it to have lunch with your mom? You 
know, my mom had already passed away at 59. Our family is not very long. So 
how important is it to make time for lunch, make time for Clearwater, Florida, to 
enjoy that beach and sunshine and to make time for the little things. And to make 
sure you talk about it, because if you don’t talk about it, that doesn’t make it go 
away either. I think it had a good affect, actually. (48 year old female)
Patients also were asked if their family members had been screened as a result of 
learning of their CRC diagnosis. Twelve (n=12) patients said that their family members 
were screened. Comments from those patients who said that relatives had been screened 
are below:
…all from my experience my sisters immediately went and had Colonoscopies. 
They had immediately did.  (51 year old female)
And two of my brothers and two sisters went and got tested, and they came back 
clear… And my other brother, he had his done recently, my brother and I, he had 
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had his done about three months after I did. So, we all getting it, everybody’s 
getting it done. (66 year old male)
I told all of them. My daughter takes it. My daughter just took all her tests, and 
had her teeth done, and the whole nine yards. She was telling me the other day, 
she’s done it all. (65 year old female)
Other patients felt that their diagnosis had no effect on their FDR’s screening 
behaviors and they have not been screened for colorectal cancer:
No, my oldest brother’s, my second oldest brother is supposed to have one, get 
tested, but then I think he chickened out, his wife said ((laughs)) and he never 
went… So he missed the appointment, but I think was scared about it…They just 
can’t believe it. They just, I think it affected them a little just to think about it, but 
they’ve moved on. They are like, ‘Okay, nothing happened, I haven’t felt no 
symptoms.’ I still tell them that you need just to go get checked out. (27 year old 
female)
None. Uhn-unn. They should have, what they should have done, my two 
daughters, was went and be tested for colon cancer. In fact, the doctors told them 
to, but neither one of them have gone yet. (63 year old female)
Some patients were unsure if their CRC diagnosis disclosure had an effect on their FDRs.  
They never said anything to me about it. No, I sure don’t (know if they have been 
tested). I want to tell the truth, no. (70 year old male)
I don’t know. I haven’t talked to them about that. (80 year old female)
I don’t know. I can’t say because it don’t seem like they, you know, like they are 
bothered, but I don’t know. (75 year old female)
Four patients were hopeful and believed that their FDRs planned to get screened 
sometime in the future:
All of them said they was going to get tested anyway. So it’s just a family thing. 
Everybody going to do it, but at a time, you know, one of my brothers, my brother 
that has a church, he had made an appointment already to get his colon cancer 
done. (66 year old male)
Yeah, my, both of my daughters said they are going, and I mentioned it to my 
sons and one of them said he is going. (75 year old female)
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Yeah, my sons, you know. I have two boys, and they are really up on it now, you 
know… They plan to get it. (76 year old male)
Patients also took an active role and suggested that their FDRs get screened and 
expressed a desire for their family members to get screened.
Yeah. My children and I talked about it. I told them that they may have at what 
age they needed to start now with having being tested. (64 year old female)
I’m trying to encourage them to do it, you know… But I let them know that, you 
know, it could hit anyone, so this is, you have to take it seriously. (54 year old 
female)
I know my sisters, they were both like, “Oh, I’m making an appointment. I’m 
going there.” You know, and I’d say, “Yeah, you need to go get screened.” (51 
year old female)
Current perceptions of colorectal cancer. Patients were asked how does sharing 
a diagnosis of colorectal cancer compare to sharing other secrets or private information 
that they had to share with family members in the past. The patients in this study had a 
difficult time answering this question directly. Patient answers to this question are below:
It was easy to talk about it. It wasn’t nothing private about it. (66 year old male)
I guess we tend to be pretty open, so I didn’t consider it something that I needed 
to keep secret, or be afraid to tell them, or feel embarrassed about or anything. (51 
year old female)
I didn’t hold it from anybody because I know some of my coworkers have gone 
through cancer, I didn’t know what type of cancer they had, but I was glad they 
let me know because I could pray for them. Like I told somebody, it’s like when 
you get sick, all prayers help, as far as I am concerned. I want people to pray for 
me, you know, because I just don’t want to have to go through that by myself. Not 
just the family members. Everybody, even my aunts. They go to another church, 
but they put me on their prayer list. I’m sorry, I just, that’s my feeling. Some 
people don’t feel like that, but that’s just how I was brought up, you know. 
Prayers, prayers help, and I didn’t hold it back from anyone. (54 year old female)
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Finally, patients were asked, “Since your diagnosis, what comes to mind when 
you hear about colorectal cancer?” Most patients thought about colorectal cancer 
education and prevention:
What comes to mind is I wish we were more educated about it-and we are just 
finding out about it… If we pay more attention to it, you know, it’s better for us, 
you know. You’ve got a better chance. But when you are ignorant to it and you 
don’t want to pay a, no attention to it, “well, ain’t nothing wrong with me.” That’s 
when it really hurts. (76 year old male)
That we should always, you know, take care of our bodies, you know, get 
tested…When I hear about it in the news and see it on television and see, it’s 
becoming too common. It’s becoming, it’s something that we are eating, or 
something we are dealing with, that causes it. (65 year old female)
It’s a successful cancer, I think. Eating habits change, changing eating habits, 
exercising, you know, and I think it’s a cancer now that, I’m not going to say that 
it’s licked because cancer is cancer, I don’t think that anybody is safe, you know. 
And I just think it’s one of those cancers now you can say that, like Tuberculosis 
is now, you can say that you are going to live. You can live with that. If you do 
what you are supposed to do, you can live with it. And that’s what I think about it. 
(54 year old female)
Others discussed the lasting effects of their treatment:
I just hope they got it all when they operated. (70 year old male)
When I hear colorectal cancer, I think about, to be honest with you, the people 
that get it in my age group, at within that age group where the souvenirs of cancer 
survivors-at least the souvenirs of colorectal-colostomies. I don’t think that I 
would give anything to change surviving cancer, but at the age that I am, in 
middle age, why did I think it would be more acceptable to have a colostomy 
souvenir for my cancer survival in my later years than in my middle years. It will 
lead you to not be able to figure out intimacy. And it will lead you to still have to 
struggle with self-esteem. Well, self-esteem struggling with is easier than life and 
death terminal bed. So if you get to the point between terminal and colorectal 
where the rectum is diseased by cancer, then you throw the rectum away 
((laughs)) and you deal with the intimacy problems every step you can. There are 
supports out there that tell you how to do it. And, but it’s hard for my age group, I 
think, to get the souvenirs of cancer and to try to live through, you know, a happy, 
joyful, intimate life. (48 year old female)
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Section II: First-Degree Relatives
Age, marital status, and health insurance. The first-degree relative (FDR) 
sample consisted of 16 adults – 2 men and 14 women who had a first-degree relative 
diagnosed with colorectal cancer in the past 5 years (2004-2009). To be eligible for the 
study, the FDRs could not have a personal history of cancer. One FDR refused to 
complete the demographic section of the study. Ages of the relatives in the sample ranged 
from 31-72 with a mean age of 47 and a median age of 44 (see Table 5).
The majority of the total FDR sample were married (n=10), one was divorced, 
one was widowed, two had never been married, and one was a member of an unmarried 
couple. FDRs were also asked to indicate their insurance status and type of insurance. All 
but one FDR indicated that they had insurance. Most FDRs had private insurance (n=7), 
four had Medicare, one had Medicaid, and two had insurance through the U.S. Military.
Social economic status. In order to examine the SES, FDRs answered questions 
about education, employment status, and annual household income (see Table 6). The 
majority of the total FDR sample were high school graduates, with six obtaining a high 
school diploma, three having some college or technical school education, one completed 
college, and three completed graduate or professional school. Most FDRs were employed 
for wages (n=9), one was out of work for more than one year, one was a student, three 
were retired, and another was unable to work.
Four FDRs had incomes of less than $10,000, two had incomes of $10,000-
$25,000, one had an income of $25,001-$35,000, four had incomes of $50,001-$75,000,
three had incomes of $75,001-$100,000, and one had an income of over $100,000.
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Table 5: Sex, Age, Relationship, Marital Status, and Health Insurance (FDR)
(N=16)
Variable N %
Sex
Male 2 12.5
Female 14 87.5
Age
30-39 4 25
40-49 7 43.7
50-59 1 6.3
60-69 2 12.5
70-79 1 6.3
Missing data 1 6.3
Relationship to Patient Brother 1 6.3
Son 1 6.3
Sister 6 37.5
Daughter 8 50
Marital Status
Married 10 62.5
Divorced 1 6.3
Widowed 1 6.3
Never married 2 12.5
Member of an 
unmarried couple
1 6.3
Missing Data 1 6.3
Health Insurance
Yes 14 87.5
No 1 6.3
Missing Data 1 6.3
Health Insurance Type
Medicare 4 25
Medicaid 1 6.3
Private 7 43.8
Military 2 12.5
N/A 1 6.3
Missing Data 1 6.3
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Table 6: Education, Employment Status and Annual Household Income (FDR)
(N=16)
Variable N %
Education Completed
Some high school 2 12.5
High school graduate 6 37.5
Some college or tech school 3 18.8
College graduate 1 6.3
Graduate or professional school 3 18.3
Missing Data 1 6.3
Employment Status
Employed for wages 9 56.3
Out of work for more than one year 1 6.3
Student 1 6.3
Retired 3 18.8
Unable to Work 1 6.3
Missing Data 1 6.3
Annual Household Income
Less than $10,000 4 25
$10,000-$25,000 2 12.5
$25,001-$35,000 1 6.3
$50,001-$75,000 4 25
$75,001-$100,000 3 18.8
$100,001 or more 1 6.3
Missing Data 1 6.3
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Telephone Interviews
Semi-structured in-depth telephone interviews were conducted with the first-
degree relatives of colorectal cancer patients from May 2009-August 2009. The 
interviews were conducted with the use of an interview guide (Appendix E), which 
included a list of questions grouped by topic and domain. The approach to the interviews 
was the same as the patient interviews in that they were conducted with a preformulated 
interview guide, and answers to those questions were allowed to be fully expanded at the 
discretion of the interviewer and interviewee, and could be enhanced by probes.
All sixteen of the interviews were recorded. Each interview lasted approximately 
15-30 minutes.
First-degree Relative Telephone Interview Findings
Disclosure experience. The first part of the interview focused on the FDR’s 
experience with learning that his/her family member was diagnosed with colorectal 
cancer. This question was posed in a manner for the participant to answer freely. As
expected, the majority of FDRs had a difficult time hearing the news and ultimately 
accepting the diagnosis. They expressed shock and concern. Some of the FDR’s reactions 
are expressed below:
Well, I was concerned. I was, because you know it’s not the first person in our 
family that had this problem with colon cancer. (68 year old sister)
I was actually shocked to find out because he is one of the healthiest people that I 
know. He is the only person in the world who eats cottage cheese… So I was 
really shocked when I found out that he had cancer. Not that your diet has 
anything to do with it, but just because he’s so health conscious. (38 year old 
daughter)
It was devastating, traumatic. I wasn’t expecting that. (44 year old daughter)
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FDRs were then asked about the first three things that came to mind when they 
learned about their relative’s colorectal cancer diagnosis. This question was asked to gain 
an understanding of the FDR’s thoughts about CRC prior to their relative’s colorectal 
cancer treatment. Similar to the patient group, the majority of FDRs were concerned with 
death and were unsure if the patient would be able to survive the disease. A few of the 
FDRs’ comments about death include:
Of course, you know, death crosses your mind, and you know… (42 year old 
daughter)
I guess the first thing was I was going to lose my dad. (45 year old son)
Was my dad going to make it, you know, what’s going to happen? (32 year old 
daughter)
FDRs were also concerned about the treatment for the disease and the effects of 
treatment on the patient:
How long is he going to have to do medication? And things like that. (45 year old 
son)
What were her care options, and that was probably the biggest thing. (42 year old 
sister)
Is she going to have to go through, you know, all the usual things, like losing her 
hair, chemo, and all of that? (31 year old daughter)
One FDR expressed concerns about her own health given the frequency of 
colorectal cancer in her immediate family:
When I first learned it brought concerns to me because my mom, she also had 
colon cancer, and one of my aunts. That brought a concern to me because I know 
that I’d probably be a higher risk. (32 year old daughter)
Two other FDRs were less concerned with death, and expressed more hopeful thoughts 
when they learned of the colorectal cancer diagnosis:
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And I just said like she was going to be alright. I felt it was going to be alright. So 
I just thought on the positive side that, you know they were alright. I know a lot of 
people, you know, that had it and they came through it, you know. (71 year old 
sister)
The doctor would just treat him, you know, so it didn’t bother me too much. 
(sister of unknown age)
FDRs were asked who told them about their family member’s diagnosis. This 
question was important to learn if patients disclosed information about their diagnosis on 
their own or if FDRs were told by a third party. A side-by-side comparison of patient and 
FDR responses is provided in Section III. It was found that the majority of FDRs (n=8) in 
this sample were told about their family member’s colorectal cancer diagnosis directly by 
the patient. 
Four FDRs reported that they were told by other family members and four FDRs 
reported that they were told by the patient’s physician. Examples of answers from those 
who were told by other family members included:
I think his wife told me. He had gone to the doctor, I think, and came home and 
she called me. And I remember because I was actually at a workshop. (38 year old 
daughter)
When she first came down with it, they (family members) really didn’t tell me 
really what it was. They just told me she had to have surgery. And after she had 
surgery and I, you know, I found out what it was. (71 year old sister)
Those FDRs who were told by the patient’s physician explained how they were told:
The doctor told my sister and me that he had the cancer, and that he took pictures 
and he showed the pictures to us. (53 year old sister)
The doctor just examined him and then he called us all in and we all sat around a 
table, so he explained, you know, what was happening, and he said what he would 
have to do and things like that. (68 year old sister)
I couldn’t remember the doctor’s name, but the first time she had it, he was very 
abrupt, and he explained to me very briefly, and I just felt like a long walk, a long, 
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long way back to my car. I just couldn’t believe what he was telling me. (43 year 
old daughter)
It was also important to find out the FDRs’ perception of why the patient wanted 
them to know that they were diagnosed with colorectal cancer. In the cases where FDRs 
were told directly by the patient, most FDRs believed the patient wanted them to know 
because of his/her existing close relationship. Examples of this belief included:
Well, because, we was always, we was close. My whole family. We was very 
close, and we can’t let cancer and stuff like that keep us from each other. (68 year 
old sister)
Just because I’m his sister and kind of let each other know what’s happening with 
us. (68 year old sister)
We always talk about, you know, nearly everything, so you know. (71 year old 
sister)
The next most common belief held by FDRs of why the patient told family 
members about his or her diagnosis related to the patient’s concern about the severity of 
the disease and uncertainty about surviving colorectal cancer.
I think when he, when he got like bad on, when it came surgery time, you know 
he did, it was just like the point where you know he had to let someone know 
what was going on. (42 year old daughter)
I think at one time she was… She thought for sure she had it bad. (68 year old 
sister)
Because she was concerned. She didn’t know how bad it was going to be, you 
know what they was going to find in her. Polyps or, you know, things they were 
going to have to take out her Colon or not. (53 year old sister)
Communication context. FDRs were asked to describe the environment 
including the time and place where they were told about their relative’s colorectal cancer 
diagnosis. FDRs expressed both positive and negative experiences with being told. A few 
relatives found out face-to-face while others were told over the telephone. Three FDRs 
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found out while at the hospital or doctor’s office at the same time as the patient. In two of 
the cases, the reason was due to late diagnosis. One FDR described the status of the 
patient when he/she was told in the hospital.
… she was out of it. She was, she had had the, by the time I had got there, they 
had just pushed her into surgery, and she really was out of it. The only thing she 
could do was like nod her head. (45 year old daughter)
This same FDR felt guilty because she was not at the appointment when the 
doctor suggested that her mother should have a colonoscopy.
Then the doctor said that on one of the visits that I didn’t go with her that he had 
actually said that he wanted to set her up, to schedule her for a colorectal 
screening…she had never been screened for it. (46 year old daughter)
The majority of FDRs (n=9) were told about their family member’s diagnosis 
over the telephone compared to those who were told in the hospital (n=3) or face-to-face 
(n=4). FDR’s explained:
Well, that was the most convenient way to tell me at the time, because I wasn’t 
there. Now, they could have called all of us over and sat down and told us about
it, but it was just easier over the phone. (38 year old daughter)
Well, it was done over the phone; he called me on the phone and talked to me. (45 
year old son)
She told me over the phone, so I was in the house on the phone and she was at 
home, and she was just sharing. (42 year old sister)
FDRs also expressed what they thought were the positive consequences of being told 
over the phone. Being told over the phone allowed FDRs to hide their initial reaction 
from the patient and not observe how the patient reacted to the news of the diagnosis.
The only good thing that I could say about that is that-sometimes you are not able 
to see how the other person’s emotions are, so it’s not as hard, you know. (32 year 
old daughter)
Well, the good thing is I guess that she couldn’t see my kind of shock. (42 year 
old sister)
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It made me feel good because she was, you know, she wasn’t depressed about it 
or nothing… I know she was strong, so I just, you know acted strong with her. (71 
year old sister)
Reaction to disclosure. Also important for this study was to understand how 
FDRs reacted to the news of their relative’s diagnosis. FDRs were asked, “How did you 
react when you first learned about the colorectal cancer diagnosis?” As expressed in the 
section on the disclosure experience, most FDRs were in shock:
We were just shocked, you know. There was really nothing you could do. You 
know, you just, you’re like shocked to hear the news. (42 year old sister)
I just said, “Really?” and kind of stood there with my mouth open for a minute. 
(44 year old daughter)
Again, it was devastating, you know, and I’m saying I was in shock for a minute. 
(42 year old daughter) 
FDRs were also probed to find out if they were empathetic or if they offered to do 
or say anything to help after the disclosure. They expressed gestures of various types of 
support. Some participants expressed informational support through the provision of 
advice, suggestions, and information:
The only thing I told my dad was to be strong, and I told him, you know, I had 
confidence that he would beat it because like I said my dad is a very confident 
person, so very strong-willed, so I told him, you know, do what the doctors tell 
you to do. Make sure you are following their advice, and you will be okay. (45 
year old son)
Well, later on that night I came home and I went on my, looking it up to find out, 
because I think it was like stage 3 or 4, so I started doing my own research to find 
out. What is Colon Cancer? What is Stage 3? Where do we go from here? What is 
the treatment? What are some of his options? So I did my own research, and my 
sister was doing her research, and we kind of compared notes. Okay, well this is 
what I found, and what did you find, and there were some similarities about what 
needed to be done. (38 year old daughter)
Instrumental support in the form of tangible aid was also expressed.
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We offered you know to help and you know to help with his drugstore, you know 
work around the house. But you know, it’s been like that with some older people, 
when they are used to being, you know, independent, they really don’t want too 
much help. (42 year old daughter)
Anything she needed doing, we was there. Whatever she asked me. Bring her 
food, take her somewhere, run errands. We did anything for her. (68 year old 
sister)
…when she was in the hospital I’d go out there, and you know, and stay be 
talking and she’d be wanted me to start giving her stuff and start taking it to her. 
(31 year old daughter)
Emotional support or the provision of empathy, love, trust and care was widely offered 
among this group of FDRs:
I let him know that we are thinking about him, and you know, in touch with him 
and checking on how he was doing. (32 year old daughter)
I  went over there, you know would go over there and visit her young ones, and 
even see when she was in the hospital I’d go out there, and you know, and stay 
and be talking and she’d be wanting me to start giving her stuff and start taking it 
to her. (71 year old sister)
I just let her know I was there if she needed me. (42 year old sister)
Prayer and faith in a higher power was also expressed by FDRs in this study. 
FDRs were vocal about giving support in the form of prayer to their family members 
diagnosed with colorectal cancer. It was mostly used as a way to cope with the news of 
the colorectal cancer diagnosis.
No, I just, I didn’t cry, I just prayed about it, you know. (32 year old daughter)
You know, I just, well we just had to take it and put it in God’s hands and that 
was it. (68 year old sister)
The only advice I had was she had to trust in God through it. (68 year old sister)
Impact of Disclosure. Many FDRs (n=11) reported that their family member’s 
colorectal cancer diagnosis impacted their health positively, created an increased 
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awareness about the disease, and encouraged timely colorectal cancer screening 
behaviors. A few patients expressed how learning that colorectal cancer runs in the 
family had impacted their health behaviors.
Yes, I do work out, where I wasn’t working out and stuff, I do work out. We did 
start watching our diets around the house a little bit. I’m not going to say, we’re 
not healthy people, but you know, just things that we eat, you know, to prevent 
other illness… I’m working harder at it now and before I just always said, you 
know, I’m going to stop smoking one day. Now I said I would stop. (44 year old 
daughter)
To take better care of myself… try to eat right and exercise. (45 year old 
daughter)
Oh, I run, I play racquetball every day. I run, I watch what I eat. I try to stay away
from fried foods, and I try to, I try to get on the deal with my mom, like the fruits 
and the- it’s hard. (43 year old daughter)
FDRs (n=5) said that that their family members played an active role in 
encouraging them to get screened and talk to their physicians about colorectal cancer. 
Some suggestions that FDRs recalled included:
Well, she said that I needed to talk to my doctor to have myself checked out. (46 
year old daughter)
One of the things that my dad started letting us know, the males in our family, that 
we needed to go get this checked out. (45 year old son)
Probably it’s the only reason why I was even thinking about it, because I mean 
she says that the doctors encouraged her immediate family members to get 
screened ten years earlier than when she was diagnosed… (31 year old daughter)
As a result of encouragement from patients and learning that colorectal cancer 
impacted their families; FDRs expressed an interest in getting themselves screened for 
colorectal cancer. Several FDRs (n=9) reported that they consulted with their physicians 
and informed other family members about their possible risk for colorectal cancer:
So I think the only thing I was worried about then was, you know, maybe I need 
to get myself checked out. (45 year old son)
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Well, I scheduled myself for my first Colonoscopy. (42 year old sister)
I informed my doctor. I let my sons know that it’s a possibility that they may need 
to be (checked out), that they become older… (44 year old daughter)
Three other FDRs said that although they were aware of the disease they did not 
have all the information they needed in order to effectively prevent colorectal cancer:
Well, I try not to, well I do exercise, but I am still concerned about, you know, 
both my parents being diagnosed, and having colon cancer. I really don’t know 
what, you know, what steps you are supposed to take. (32 year old daughter)
So it made me, you know, take more heed, but I still didn’t do as much research 
as I probably should have or could have. (32 year old daughter)
It had a lot of impact because the first thing-well, then you start thinking, is that 
hereditary? Will my children have it? Will I have it? Is this a one-time deal? Is it 
just individual cases? Where does it go from there? (38 year old daughter)
Other FDRs (n=4) concluded that the patient’s diagnosis did not have any impact 
on them and they would not do anything differently about their health as a result of 
learning about their family member’s diagnosis. 
I never planned on going anyway… Am I concerned about my OWN health? Not 
really. (32 year old brother)
No, not that I know of.  Nothing that I know that I need to do differently. (71 year 
old sister)
No, it really didn’t because, I don’t know, she just said it wasn’t serious. (68 year 
old sister)
Current Perceptions of Colorectal Cancer. The concluding question of 
the FDR interview asked, “When you think of CRC now, what comes to mind?” FDRs 
mentioned family and the ability to survive colorectal cancer. One comment about family 
history was:
My family. I mean, that’s about all that really comes to mind. My mom had had it 
and now here I think it’s not just my mom that had it, my dad has had it, and 
that’s basically, you know, some of my concerns, as far as things that come to 
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mind. Two of my, you know, biological, you know parents have had Colon 
Cancer so that’s the first thing that I listen. If I hear something about it, I will 
listen. (32 year old daughter)
In terms of survival, FDRs had a positive outlook of CRC as a result of having a family 
member survive the disease with few complications:
I think it is something that you can deal with and you can get through. It’s not 
like, “okay, this is the end of the world.” (38 year old daughter)
I know it’s one of the cancers that, you know, if caught soon enough, it can have a 
very good outcome in many cases… (42 year old sister)
To keep it going, you know, keep whatever tests for the problem. The great thing, 
even though they can test you for problems, you can survive it. (68 year old sister)
Section III: Family Group Comparison
Description of family groups. There were five family groups analyzed for this 
study.  A family group consisted of a patient who had two or more FDRs participate in 
the study.  There were three female and two male patient families analyzed.  Each 
individual’s responses were analyzed to compare the similarities and differences among 
the responses of the patients and corresponding FDRs within each family. 
Family group 1. Family group 1 was comprised of a 51 year old female patient, 
her 31 year old daughter, and her 42 year old sister. The patient’s responses were 
consistent with her FDR responses and it appeared that the patient had a good 
recollection of her diagnosis experience. The description the patient gave about when and 
how she told her family members corresponded with her FDRs’ memories of the event.  
The patient remembered her family being shocked by the news of her diagnosis and the 
FDRs also expressed their shock and fear upon learning of the diagnosis.  The patient felt 
well-supported by her family and the FDRs expressed that they made the patient aware 
that they were available to give support.  The patient felt that her FDRs became more 
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aware of colorectal cancer because of her experience and stated that all of her sisters had 
colonoscopies as a result.  The patient’s 42 year old sister stated that she has been 
screened for a colorectal cancer and would not have otherwise been screened, if not for 
the patient’s diagnosis. The 31 year old daughter said she was aware of her increased risk 
and planned to get a colorectal cancer screening exam ten years earlier than the age her 
mother was diagnosed with colorectal cancer. Details of the family group 1 analysis are 
visible in Table 7.
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Family group 2. Family group 2 included a 70 year old male patient, his sister of 
unknown age, and his 42 year old daughter. The patient and his daughter thought about 
death when they first learned of the patient’s diagnosis. However, the sister was not very 
worried because she felt that the cancer could be treated. Within family group 2, there 
were differences in the description of how the patient informed his FDRs about his 
diagnosis. The sister and daughter both said that they did not know her brother had cancer 
until the doctor told her at the time of the surgery. However, the patient felt that he told 
his family members individually, at home before his surgery. 
The major reason the patient said he told his family members about his diagnosis 
was because he wanted support from his family. His sister felt as if the patient wanted her 
to “fix him up in some way,” while his daughter felt as if he told his family as a last 
resort after he realized the seriousness of his illness. The patient felt as if his family 
members would not get screened as a result of learning about his diagnosis. Neither the 
sister nor the daughter of the patient committed to getting screened for colorectal cancer. 
The sister said she would consider talking to her doctor about screening and the daughter 
planned to take better care of herself by going to the doctor more often. A closer look at 
family group 2 is available in Table 8.
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Family group 3. Family group 3 was comprised of a 65 year old female patient 
and her two daughters aged 43 and 45.  The patient’s main reason for disclosing to her 
family was because she wanted them to be prepared in case she passed away. Her two 
daughters both said that she told them because she wanted them to take care of her assets 
and responsibilities. The 45 year old daughter also agreed with the patient, and said that 
she wanted them to be aware of what she was going through in terms of her health. The 
patient admitted that she didn’t tell her family about her diagnosis right away; she waited 
for the right time and then told her younger daughter who lives nearby. The younger 
daughter also said that her mother told her. The older daughter who lived out of state was 
told by her sister at the time of her mother’s surgery.
The patient felt that she was supported very well and her daughters managed 
everything for her while she was ill. The patient’s daughters also said that they supported 
their mother and described the different types of support that they provided. The patient 
hoped that her daughters take better care of their bodies as a result of learning about her 
colorectal cancer diagnosis. She also believed that both of her daughters had been 
screened for colorectal cancer. However, neither of the daughters was screened but both 
planned to get screened in the future. Additional comparisons within family group 3 are 
listed in Table 9.
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Family group 4. Family Group 4 included a 64 year old female patient and her 
two older sisters, one 68 years old and the other 71 years old (see Table 10).  Within this 
family group, each FDR believed that the patient disclosed her diagnosis for a different 
reason. The patient said that she disclosed so that her FDRs knew what they could expect 
from the patient including what she was able and unable to do while ill. The 68 year old 
sister believed she disclosed because of their close relationship and to encourage her to 
get screened again. The 71 year old sister believed the patient disclosed so that she could 
get support and assistance when needed. The patient remembered calling her sisters on 
the phone to tell them about her diagnosis. One sister remembered being told over the 
phone. The 71 year old sister remembered being told by another sister (not the patient) 
and was only told that the patient had to have surgery. She only found out that the patient 
had colorectal cancer after the patient completed treatment, not colorectal surgery 
specifically. The patient remembered her sisters being calm when they found out she had 
to have surgery and the sisters also agreed that they reacted calmly. In terms of colorectal 
cancer screening, the patient believed that one of her sisters had been screened. In fact, 
both sisters were screened previously; however one sister was unsure when she should be 
screened again.
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Family group 5. Family group 5 was the largest of all the family groups and 
consisted of a 76 year old male patient, a 45 year old son, a 44 year old daughter, a 38 
year old daughter, and a 32 year old daughter.  The first thing that came to the patient’s 
mind when learning of the diagnosis was that he could survive the illness.  The patient’s 
son and 44 and 32 year old daughters were concerned with the possibility of death. The 
38 year old daughter was concerned about what to do next. 
The patient stated that he told all of his children about his diagnosis himself. The 
patient’s son and the 44 year old daughter agreed that they were told directly by the 
patient. However, the 38 and 32 year old daughters said that they were told by their step 
mother. The patient said that he disclosed so that if he became extremely ill, his children 
would be aware of why he was ill.  The patient also expressed that he needed his 
children’s strength and support.  All three of the patient’s daughters agreed that the 
patient disclosed in order to get support. However, the patient’s son felt as if the patient 
was pressured by his step mother to disclose and that the patient disclosed unwillingly. 
In terms of disclosure effects, the patient said that he now has a closer relationship 
with his children and that they pay more attention to their health. The patient’s 45 year 
old son and 44 year old daughter recall that the patient stressed the need for the men in 
the family to get tested for colorectal cancer. The 38 and 32 year old daughters were 
concerned with the familial risk for the disease. Additional comparisons of family group 
five are presented in Table 11.
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Summary
This study was initiated to explore a topic for which little research has been 
conducted. Analysis of the data was conducted with the goal of answering the research 
questions for the study. Semi-structured, in depth, face-to-face interviews and semi-
structured in depth telephone interviews were conducted to examine perceptions and 
descriptions of how family support and closeness to the patient impacts disclosure to 
first-degree relatives and how this disclosure influences the CRC screening activities in 
African American families. 
Section I reported on the patient study goals, the first of which was to determine 
which factors influence a patient’s decision to reveal a CRC diagnosis to a family 
member. In this study, qualitative methods were employed to elicit details of patients’ 
disclosure of a colorectal cancer diagnosis to first-degree relatives and the criteria 
patients use to decide whether or not to disclose their diagnosis. It was found that severity 
of the disease, closeness to family and FDR risk for CRC were the factors that appeared 
to have the most influence on disclosure. The second goal of the study was to determine 
the utility of the Family Secrets framework and explain what decision-making criteria 
patients use to help them decide to disclose a CRC diagnosis. The qualitative interviews 
examined each construct including whether issues such as the patient’s well-being, the 
anticipated response from the confidant, the communication context, the patient’s 
perceived impact of the disclosure on family members, and the reward associated with 
disclosure influence a patient’s decision to disclose. It was found that each construct from 
the framework was relevant and apparent in the data.  The third goal of the research study 
was to examine what roles the four types of social support play in a patient’s decision to 
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disclose their diagnosis to a first degree relative. It was found that emotional support had 
the strongest influence on the decision to disclose. Patients said that they expected 
emotional support from their first-degree relatives in the form of prayer, visitation, and 
expressions of care and concern.
Section II reported on the FDR study goals and employed the use of semi-
structured telephone interviews with the first-degree relatives of the patients. The fourth 
goal of the research study questions was to determine how first-degree relatives perceive 
the information they received about the patient’s diagnosis. The FDRs in this study 
perceived the diagnosis as fatalistic, an expression of closeness to the family, and an 
opportunity to provide social support. The fifth goal was to understand how diagnosed 
patients influence the screening behaviors of first degree relatives through the four types 
of support. It was found that patients influence the health and screening behaviors of 
FDRs primarily through informational support.  Section III was a side-by-side analysis of 
related questions from the patient and FDR interviews guides. This analysis compared the 
results of the family groups from Section I and Section II in order to determine if patient 
and FDR responses were congruent. It was found that: patients said they were completely 
open while FDRs felt patients were reluctant to disclose; patients turned to faith and 
prayer to help cope with the diagnosis; and FDRs offered prayer to patients. There were 
discrepancies between patient beliefs about FDR screening actual FDR screening 
behavior. Further discussion of the results will be presented in Chapter V.
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Chapter V
Discussion and Conclusions
This chapter discusses the results of structured interviews conducted with cancer 
patients and their first-degree relatives Contributions of this research to theory and public 
health will be described. The limitations of the study will be delineated, along with 
recommendations for future research directions. 
Colorectal Cancer Disparities
Cancers of the colon and rectum have higher incidence, mortality, and later stage 
of detection rates for African Americans than for whites (ACS, 2008). Screening is a 
critical measure in the prevention of CRC due to its ability to identify and remove pre-
cancerous polyps that may take years to develop into cancer. Studies have shown that in 
African American populations, a higher percentage of CRC occurs in patients under the 
age of 50 (Agrawal et al., 2005; Kanna, Schori, Azeez, Kumar, & Soni, 2007).  In the 
current research study, a large number of patients waited for symptoms before they 
decided to schedule a doctor’s appointment or make a trip to the emergency room and 
two patients were under the age of 50 when diagnosed. It was also common for them to 
have never had a colonoscopy before being diagnosed. Instead, patients explained that 
they experienced pain and bleeding before they sought treatment.  
Patients also explained that they felt uninformed about colorectal cancer and their 
treatment options before and after treatment. During one interview, the patient asked the 
interviewer if he really needed to do a follow-up colonoscopy after treatment. This 
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provides evidence for the fact that even after treatment, patients are unsure of how to 
prevent reoccurrence of colorectal cancer. 
People who have a first-degree relative with colorectal cancer are about twice as 
likely to develop the disease as those with no family history of the disease (ACS, 2008).
For this reason, it is important for first-degree relatives of colorectal cancer patients to 
understand the screening recommendations for prevention and early detection. The FDRs 
in the current study reported that they realized colorectal cancer runs in their families, but 
FDRs were unaware of how to actively prevent colorectal cancer. This is consistent with 
previous literature that reported that African Americans who have first-degree relatives 
with CRC are less likely to participate in colonoscopy screening and less likely to have 
endoscopic procedures before age 50 compared to whites with affected relatives (Murff et 
al., 2008).
Health care providers may underestimate the impact that they have on an 
individual’s decision to get screened. Powe and Adele-Kelly (2005) reported that patients 
may not be aware of the benefits of screening unless their health-care professionals 
discuss it with them. They also state that it is possible that healthcare providers have their 
own beliefs, and judgments about colorectal cancer that impacts their decision to 
recommend screening. A previous study by Fletcher (2002) reported that physicians who 
do not believe in the importance of colorectal cancer screening may communicate their 
lack of conviction to their patients. Colorectal cancer screening can also be viewed 
negatively by providers due to the cost, time constraints, and lack of reimbursement (Rex, 
2002).
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According to the American Cancer Society (2009), a family history of colorectal 
cancer increases one’s chances of developing colorectal cancer. Individuals with a family 
history of CRC or adenomatous polyps in any first-degree relative younger than age 60,
or in two or more first-degree relatives at any age are considered at increased risk for 
CRC (ACS, 2009). A study by Kupfer, McCaffrey, and Kim (2006) found that black 
patients, especially men, were significantly less knowledgeable of paternal family cancer 
history than maternal family history compared to whites. This is troubling because one 
must be aware of his/her family history in order to participate in timely screening.
Disclosure
The manner in which the patients in the current study disclosed their diagnosis to 
family members depended on the severity of disease. Many patients in the current study 
waited for symptoms before being screened, and were hospitalized and/or underwent 
surgery before they were faced with the decision to disclose their diagnosis to family 
members. In these cases, the cancer was more severe, and FDRs often learned about the 
diagnosis and severity of disease at the same time as the patient. In some instances, the 
doctor informed family members waiting at the hospital, rendering disclosure out of the 
patient’s control. This is consistent with a study by Henderson, Davison, Pennebaker, 
Gatchel , and Baum (2002) that found disclosure of a breast cancer diagnosis was 
predicted by severity of disease, with greater severity associated with more disclosure. 
In contrast, patients who first learned about their CRC as a result of a 
colonoscopy had time to contemplate disclosure and decide whom to tell. In a study by 
Hallowell et al. (2005), patients described three communication strategies for disclosure 
of a genetic risk to their children: 1) complete openness, 2) limited disclosure, and 3) 
103
total secrecy. In the current study, only the first two strategies were reported. Many 
patients said they had been completely or partially open in revealing their diagnosis. 
Another strategy reported was delayed disclosure in which patients told some FDRs right 
away, while waiting to tell others until they had more information about their diagnosis, 
waiting until they felt the time was right, or telling them when they felt they needed to 
know. None of the participants in the study reported that they maintained total secrecy. 
The extent of disclosure also varied within the study population. All participants 
informed at least one family member about their CRC diagnosis. Some patients said they 
had been completely open with family members (and even some co-workers); however, 
in some cases their FDRs felt this disclosure was done reluctantly. These FDRs believed 
that the patient told them, despite their reservations, because it would be difficult to hide 
the illness or because they wanted the FDR to become aware of the importance of CRC 
screening.
These findings reinforce those of Gray, Fitch, Phillips, Labrecque, & Fergus
(2000) who reported that, the perception of the other person’s right or need to know about 
a prostate cancer diagnosis was a major factor motivating disclosure among Canadian 
patients. Though some of the Canadian patients in the study said it was difficult to 
communicate the news to FDRs, there was a felt sense of obligation to let FDRs know 
about their familial risk. For example, one patient in the current study who practiced 
limited disclosure told most FDRs but did not tell her youngest daughter because she did 
not want her to know that she was dying. The patient was careful to avoid using the word 
“cancer” in the child’s presence.  Another patient in the current study who displayed 
limited disclosure said that she informed all of her family members. However, after an 
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interview with her sister, it was found that the patient only told her that she was having 
surgery and never mentioned that she was having surgery for cancer. 
Delayed disclosure also occurred among this study’s patients. Some patients 
waited until they were sure they were going to survive the disease or had more 
information on the treatment options before informing all FDRs.  One patient avoided 
telling a sister for over one year because the patient believed that her sister was favored 
as a child. This case is consistent with Afifi et al. (2005), who reported that individuals 
may refrain from revealing a secret for fear of judgment and ridicule, or concern that the 
information would be used against them. Unlike Afifi et al.’s (2005) findings, the patient 
in this study reluctantly told her sister about her diagnosis in an effort to make amends 
with her sister.
CRC patients reported that they often experienced distress when they 
contemplated disclosure of their CRC diagnosis to FDRs.  Patients wanted to protect their 
family members from the possible stress, worry, anxiety, and fear that they believed 
FDRs would experience on account of their illness. Afifi et al. (2005) asserts that people 
keep secrets because they are afraid the revelation will hurt the target of the secret, 
damage their relationship with that person, or impact other family members. Additionally 
Hilton et al. (2009) found that telling family and friends about a cancer diagnosis was one 
of the hardest aspects of having cancer.
Patients in the study also said they experienced relief after disclosing a diagnosis 
to FDRs. This could be due to the receipt of social support that the patients in this study 
received from family members. Because most FDRs in the current study reacted 
positively, the patients may have been more likely to have positive feelings towards 
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disclosure. Patients reported feeling more comfortable talking about CRC to their FDRs 
if their prognosis looked positive. This finding suggests that one’s prognosis might affect 
a patients’ comfort with the disclosure process. 
FDR Screening
Some (n=6) of the patients in the current study said they encouraged their FDRs 
to participate in CRC screening and to make lifestyle changes in terms of diet and 
exercise. This is likely because these patients understood the importance of a healthy 
lifestyle and early detection in the prevention of colorectal cancer.
Most FDRs reported that learning of their relative’s disease influenced their 
screening intentions and other health behaviors believed to prevent CRC. Nine (n=9) 
reported that they planned to get screened in the future because of their increased risk,
and some also reported that they increased their exercise, changed their diets, and made a 
stronger attempt to quit smoking after learning of their familial risk for CRC.
In contrast, other FDRs reported that they did not change their future plans after 
the disclosure. They said that they were more aware of their CRC, but they were unsure 
about the protective measures to take besides screening. In two cases, FDRs were also 
unwilling to be screened. One man, a 32 year old brother of a female patient diagnosed in 
her 20’s, also reported his mother was diagnosed with CRC at a young age. He explained 
that he was fearful of finding cancer and, uncomfortable with screening procedures that 
involved the rectum because he believed that procedures in that area were associated with 
homosexuality. Men’s adherence to an idealized form of masculinity can have 
consequences on their health when they reject behaviors that they associate with 
femininity or homosexuality (Courtenay, 2000). Another FDR in her seventies said that 
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she didn’t plan on getting screened because her physician never told her it was necessary, 
but she did plan to discuss it during her next doctor’s appointment. This case points to the 
importance of a physician’s recommendation for screening. In a study by Madlensky, 
Esplen, Gallinger, McLaughlin, & Goel (2003), it was found that the strongest predictor 
of CRC screening was physician encouragement. 
Spirituality
Prayer and faith played an important role in how patients and their FDRs coped 
with their diagnosis and treatment. Many patients turned to their faith in a higher power 
and prayer to help them cope with CRC and to improve their chances of surviving the
disease. FDRs also offered prayers as a type of social support they provided to their 
relatives after the diagnosis.
These findings are consistent with Bowie, et al. (2004) who found religion and 
spiritually to be significant personal and cultural resources within many racial and ethnic 
traditions and offer a context for promoting health and individual well-being. For African 
Americans, the church plays a critical role in the lives of most African-American adults 
in the southern United States; it has the unique ability to meet various spiritual,
economic, social and cultural needs of the black community (Blocker et al., 2006).
Contributions to Theory
This research study’s contribution to theory includes the exploration of a new way 
to understand the disclosure process in an African American population. The Family 
Secrets and the Social Support Frameworks were the basis for this study, and it was 
interesting to find that both were relevant to the population of interest. The use of the 
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Family Secrets Framework is a new contribution to public health theory because it has 
not been used specifically to help explain disclosure of a chronic disease such as cancer. 
A family secret is any information that directly affects or concerns a person but is 
either withheld or differentially shared between or among family members (Brown-
Smith, 1998). According to Brown-Smith (1998), the family is of specific interest in the 
study of secrets because it is considered to be the most important social organization and 
emotional environment that individuals encounter. Given this assertion, it is important to 
understand what people consider when they reveal secrets because disclosing family 
secrets can have substantial influences on individuals and their interpersonal relationships 
(Vangelisti et al., 2001). The current study adds to the existing family secrets literature 
because it uses the criteria for revealing family secrets to study the disclosure of a disease 
diagnosis to family members. To the researcher’s knowledge, there are no existing 
studies that have used the Family Secrets Framework in this manner. In the past, the 
study of family secrets typically focused on issues thought to be taboo such as child 
abuse or drug use. Therefore, the current study has established that this framework is 
useful for understanding disease disclosure. Tables 12 and 13 provide a visual 
representation of how the Social Support and Family Secrets Frameworks are evident in 
the results of the patient and FDR interviews.
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Table 12: Evidence of Theory in Patient Responses
Theory 
Construct
Interview
Question
Example of patient response
Family Secrets Framework
The secret 
threatens  one’s 
own well-being 
both physically 
&
psychologically
What was
the major 
reason 
you 
decided to 
tell?
“I don’t know how it was going to come out. ((laughs)) Whether I was 
going to pass or what.”
The anticipated 
response from a 
confidant is 
positive
What was 
the major 
reason 
you 
decided to 
tell?
“I expected they was going to come visiting, you know, see about me, 
which they did.”
The 
communication 
context creates 
an opening for 
disclosure
When did 
you feel it 
was an 
appropriate 
time to 
reveal your 
diagnosis?
“…so I guess in some ways it probably was a little easier to do it over the 
phone, because then you, there is that little bit of a, that distance of while 
they are absorbing it mostly, in fact I think, yeah, probably it’s a little 
easier.”
The impact of 
the disclosure 
on family 
members is 
positive such as 
receiving social 
support
What was 
the major 
reason 
you 
decided to 
tell?
“I didn’t expect anything else, except to be here and be with me at least a 
week or two, you know, after. Of course, if she hadn’t been here, my 
granddaughter would have been here.”
When the 
disclosure itself 
brings some 
reward 
What was 
the major 
reason 
you 
decided to 
tell?
“…all from my experience my sisters immediately went and had 
Colonoscopies. They had immediately did. “
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Table 12: Evidence of Theory in Patient Responses (Continued)
Theory 
Construct
Interview
Question
Example of patient response
Social Support Framework
Emotional 
Support-
provision of 
empathy, love, 
trust, & caring
How did 
they 
actually 
respond or 
react to 
the news?
“Oh, they was there the night I went up to the surgery and up until I came 
home. They go home and rest, because they got kids, so they’d go home 
and they’d rest, and they’d come right back.”
Instrumental 
Support-
provision of 
tangible aid 
and services 
that directly 
assist a person 
in need
How did 
they 
actually 
respond or 
react to 
the news?
“My daughter took over cooking and cleaning actually; Everybody said if 
you need me, call me; My daughter, my sons takes me to work and my 
daughters pick me up.”
Informational 
Support-
provision of 
advice, 
suggestions,& 
info that one 
can use to 
address 
problems
How did 
they 
actually 
respond or 
react to 
the news?
“My children and I talked about it. I told them that they may have at what 
age they needed to start now with having being tested.”
Appraisal 
Support-
provision of 
info that is 
useful for self-
evaluation 
(constructive 
feedback, 
affirmation, & 
social 
comparison)
How did 
they 
actually 
respond or 
react to 
the news?
“They was just saying it’s something that God planned. You know, it’s 
something like it’s out of your control, you know?”
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The face-to-face interviews were used to determine whether constructs, such as 
the patient’s well-being, the anticipated response from the confidant, the communication 
context, the patient’s perceived impact of the disclosure on family members, and the 
reward associated with disclosure, influence a patient’s decision to disclose. It was found 
that the constructs were relevant to the current study: 1) the secret threatens one’s well 
being: In the current study it was apparent that some patients experienced a 
psychological burden of carrying the news of a diagnosis before disclosure occurred; 2)
the anticipated response from a confidant is positive: Patients expected their FDRs to 
be nonjudgmental and were hoping for a new perspective on the challenges associated 
with being diagnosed with colorectal cancer; 3) communication context creates an 
opening: Patients told their FDRs about the CRC diagnosis individually, in person and in 
groups. They also told FDRs over the telephone. Finding the right time to disclose 
appeared to be influenced by the family structure, e.g. whether the FDR lived nearby, the 
age of the FDRs, or if the FDR would be able to assist in some way. The variability of 
when and how a patient decided to tell family members was a personal decision which 
supports the notion that people are more likely to discuss personal or intimate issues in 
some social contexts more than others; 4) the impact of disclosure on family members 
is positive: In the current study, patients wanted to inform family members that 
colorectal cancer runs in the family. In this context, revealing a diagnosis has the 
potential to save a family member's life if an FDR takes appropriate prevention measures; 
5) the disclosure itself brings some reward: In addition to prayer, patients expected 
some form of social support from their family members after disclosure.
111
Another goal of the research study was to examine the role support plays in a 
patient’s decision to disclose their diagnosis to a first degree relative. Most patients stated 
that they did not expect social support from their family members to result from telling 
them about their colorectal cancer diagnosis. However, when further probed, those who 
stated that they did not expect social support admitted that the support they received was 
welcomed and expected. Patient descriptions of the different types of support received 
are also included in Table 12.
Support for the Family Secrets Framework was also found in the FDR responses
(see Table 13). FDRs described several reasons for patient disclosure. It was interesting 
to discover that their explanations were consistent with the constructs from the Family 
secrets Framework. For example, FDRs believed that patients revealed their diagnosis 
because the secret threatened the patient’s well-being, because the patient thought the 
FDR would have a positive response, because they had a convenient time and location to 
reveal, because the FDR would provide social support, and because they wanted the FDR 
to take preventive measures against CRC.
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Table 13: Evidence of Theory in FDR Responses
Theoretical 
Construct
Interview
Question
Example of patient response
Family Secrets Framework
The secret threatens  one’s 
own well-being both 
physically & psychologically
Why do you think s/he 
told you?
“Because she was concerned. She didn’t know 
how bad it was going to be, you know what they 
was going to find in her…”
The anticipated response 
from a confidant
is positive
Why do you think s/he 
told you?
“Anything she needed doing, we was there. 
Whatever she asked me. Bring her food, take her 
somewhere, run errands. We did anything for 
her.”
The communication context 
creates an 
opening for disclosure
Was the environment 
good for that type of 
conversation
“Well, that was the most convenient way to tell me at 
the time, because I wasn’t there. Now, they could 
have called all of us over and sat down and told us 
about it, but it was just easier over the phone.”
The impact of the disclosure 
on family members 
is positive such as receiving 
social support
What do you think 
your family member 
expected from you by 
telling you about their 
diagnosis?
“The reason why she told me about it was she 
wanted me to take care of her.”
When the disclosure itself 
brings some reward
What do you think 
your family member 
expected from you by 
telling you about their 
diagnosis?
“To encourage other family members to get 
screened earlier and things like that…”
Social Support Framework
Emotional Support-
provision of empathy, love, 
trust, & caring
How did you react 
when you first learned 
about the CRC dx? 
“I mean, just be, come to her, you know, come 
to her and be there if she needed me.”
Instrumental Support-
provision of tangible aid and 
services that directly assist a 
person in need
How did you react 
when you first learned 
about the CRC dx? 
“I went home and helped my step dad out with 
the house, the housework and the running of the 
house, with her recuperation.”
Informational Support-
provision of advice, 
suggestions,& info that one 
can use to address problems
How did you react 
when you first learned 
about the CRC dx? 
“…so I started doing my own research to find 
out. What is Colon Cancer? What is Stage 3? 
Where do we go from here? What is the 
treatment? What are some of his options?”
Appraisal Support-
provision of info that is 
useful for self-evaluation 
(constructive feedback, 
affirmation, & social 
comparison
How did you react 
when you first learned 
about the CRC dx?
“The only thing I told my dad was to be strong, 
and I told him, you know, I had confidence that 
he would beat it because like I said my dad is a 
very confident person, so very strong-willed, so I 
told him…”
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An important goal of the study was to understand how diagnosed patients 
influence the screening behaviors of first degree relatives through the four types of 
support. It was found that informational support from patients had the strongest influence 
on FDR screening behaviors. FDRs reported that patients advised them to get screened 
for colorectal cancer and to talk to their physicians about the importance of screening. 
FDRs also expressed that learning about a colorectal cancer diagnosis within the family 
increased awareness about the disease including the importance of timely colorectal 
cancer screening behaviors. Although the other types of support were not reported by 
FDRs as having a strong influence on their screening behaviors, the framework proved 
valuable as FDRs expressed how they reacted to the news of their family members’ 
diagnosis. It was found that FDRs offered all four types of support to their loved ones;
however instrumental and emotional support were provided most frequently.
Contributions to Public Health Practice
The current study investigated the perceived barriers, facilitators and criteria to 
disclosing a colorectal cancer diagnosis to first-degree relatives of colorectal cancer 
patients. This research is important because there has been little empirical research 
exploring the criteria people employ in deciding whether to reveal a family secret 
(Vangelisti et al., 2001). Results are especially important for the African American 
population given the high incidence and mortality of CRC among this group. 
Though the patients in this study were willing to share their diagnosis with certain 
family members, the FDRs in the study described some of the challenges that the patients 
had with disclosure. Disclosure of the diagnosis was stressful for patients and FDRs.
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Understanding the experience of the diagnosed patient is important for the design 
of interventions that assist patients with the disclosure process. It also highlights the 
patient’s need for assistance coping with the impact of diagnosis. Many people go 
through a time of grief and sadness when they first learn that they have cancer. They 
grieve the loss of health and the loss of certainty in their lives (ACS, 2009). Although this 
coping response is normal, it is difficult for most clinicians to fully understand the 
experience of the patient (Jacobsen & Jackson, 2009).
In order for oncologists to communicate effectively in these difficult situations, it 
is helpful to assess what the patient knows and wants to know about his/her disease in 
general and, specifically, his/her prognosis (Jacobsen & Jackson, 2009). This is 
consistent with the current study in which patient barriers included fear and concern 
about how their family members would respond to the news of their diagnosis. These 
results suggest that patients should be given a firm understanding of CRC and their 
prognosis. Once patients have a better understanding of what to expect in terms of their 
treatment, prognosis, and preventing a reoccurrence, they are more confident in their 
ability to talk about it with their family members.
This study underscores the importance of effective communication between 
physicians and their patients in terms of CRC treatment and prevention measures. Some 
patients and FDRs reported that they relied on their physician’s advice to determine 
whether or not they needed to be screened. Unfortunately, some patients in the current 
study were unclear about their treatment options and how they could effectively prevent 
CRC in the future. The need to develop communication strategies and tools to encourage 
physicians to assess the need for screening and promote it when appropriate is clear. A
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study by Madelensky et al. (2003), found that the strongest predictor of CRC screening 
was physician encouragement. They additionally found that physician recommendation is 
a strong and consistent correlate of screening behavior. Patients in the current study said 
that their physicians never recommended screening for CRC before they had symptoms. 
Given this information from the current study and the important impact of physician 
recommendation on patient screening noted in the literature, it may be feasible to develop 
guidelines for physicians to promote CRC screening to patients and to incorporate 
screening into routine physical exams. Additionally, physicians should inform CRC 
patients about the possible familial risk for CRC and direct them to resources that deal 
with the psychosocial affects of diagnosis and disclosure.
This study also suggests that CRC patients can play an important role in 
communicating familial risk to FDRs. Upon learning that they had a family member with 
CRC, most FDRs became interested in how they could prevent it. Many FDRs requested 
additional educational materials from the interviewer in order to get more information 
about CRC. Many were screened and some reported making lifestyle changes after 
learning of their familial risk. 
Finally, the African Americans in the study mentioned faith and spirituality as an 
important contribution to coping with CRC.  This information is important for the 
incorporation of sociocultural beliefs including the role of spirituality in interventions 
that assist CRC patients with the coping and disclosure of a diagnosis. According to 
Kreuter, Lukwago, Bucholtz, Clark, & Sanders-Thompson (2003), a sociocultural 
approach to health information and messages is one in which a group’s cultural values, 
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beliefs, and behaviors are recognized, reinforced, and built on to provide a context and 
meaning to health information and messages. 
It is important to understand that incorporating cultural values and beliefs alone 
may not be enough to impact behavior change (Kreuter & Haughton, 2006). A study on 
tailoring cancer prevention and screening information for African American women 
found that only when cultural tailoring was combined with behavioral tailoring did it 
emerge effective in promoting mammography or increased consumption of fruits and 
vegetables (Kreuter & Haughton, 2006). It also suggests that health communication based 
on constructs from health behavior change theories may be more effective in some 
population subgroups when presented in a meaningful context such as culture. The 
current study provides evidence for the importance of spirituality in the lives of African 
American CRC survivors and their families. Additionally, the use of the family secrets
framework in this study lays the groundwork for the future development of cultural and 
behavioral interventions for this population.
Overall, it is important to build commitment from communities, through 
community-based participatory research (CBPR) methods  and to include community-
and church-based interventions that are aligned with cultural norms and include 
community (Robillard & Larkey, 2009). Based on the results of this study, possible 
interventions include the development of culturally tailored navigator program for 
recently diagnosed CRC patients and other patients at risk for CRC including FDRs. 
Patient navigation is a process by which an individual (patient navigator) guides patients 
with a diagnosis or possible diagnosis of cancer through the complex cancer health care 
system to help ensure timely diagnosis and treatment (Oluwole et al., 2003). This patient 
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navigator program may prove effective in assisting patients who are unsure about how to 
prevent a future reoccurrence of CRC and for FDRs who have an interest in taking 
appropriate preventive screening measures. 
Since the importance of spirituality was mentioned frequently in the current study,
community and church-based interventions using lay health advisors may have a positive 
influence on CRC prevention in the African American community. The Witness Project, 
a program in which female African American breast cancer survivors teach their peers 
about breast cancer and early detection through telling their stories has shown promise 
for promoting the health of African Americans (Erwin, Spatz, Stotts, Hollenberg, & 
Deloney, 1996). It would be worthwhile to develop a similar program for colorectal 
cancer in which CRC survivors share their stories with newly diagnosed patients and 
those at high risk for the disease. Survivors could also discuss the challenges associated 
with disease disclosure and the potential pros and cons of disclosure.
Strengths and Limitations
The primary strength of the present study was the engagement of African 
American colorectal cancer survivors and their FDRs in a discussion about their internal 
disclosure decision-making process. Relatively little research has been conducted with 
African American CRC patients. Additionally, this study used a two-phase research
design to study the disclosure process from both the patient and their FDR perspectives,
and allowed for comparison of the results through the analysis of family units comprised 
of the patient results and the results of two or more FDRs. This unique contribution 
delves further into the disclosure process among family units. Neuman (2003) suggests 
that this process of observing the same phenomena from different angles or viewpoints to
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get a fix on its true meaning is called triangulation (Neuman, 2003). He also asserts that it 
is better to look at something from several angles than to look at it in only one way.  
Triangulation of the theoretical frameworks was also used in the planning of the research 
and in the interpretation of the data. 
Given the emotionally laden nature of colorectal cancer, individual interviews 
were conducted to obtain an emic view of the disclosure process. Patients and FDRs were 
able to describe their experiences in their own words, providing insights difficult to 
obtain from a survey.  In terms of data analysis, the researcher employed a double-coding 
technique which allowed for verification of codes and themes among more than one 
person. According to Barbour (2003), this exercise’s value rests on content and nature of 
any disagreements rather than the extent of agreement. Barbour (2003) also states that the 
dialogue between team members feeds back into and informs the development of a 
coding frame. Such a session reproduces in microcosm the process of qualitative research 
itself and maximizes the analytic potential of exceptions or potential alternative 
explanations.
The use of the constant comparative method allowed for the development of 
themes which focused on how individuals interact in relationship to the phenomenon 
under study, in this case the disclosure of a CRC diagnosis (Dey, 1999). A benefit of this 
method is that the results are traceable to the data so that review of the data at a later time 
would produce the same results (Strauss & Corbin, 1994).
Finally the use of Atlas.ti, a qualitative data analysis software, created a greater 
potential for the study methodology and analysis to be replicated in future studies 
because it functions as a documentation center, recording all the category definitions, 
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coding rules, and the steps of analysis of all interpreters. The program also facilitates the 
recording of source detail, the time and date of the data collection, storage, and search 
capabilities (Baxter & Jack, 2008).
This study is not without limitations. As with many studies of African American 
patients, this study included relatively few men (Corbie-Smith, Thomas, Williams, & 
Moody-Ayers, 1999; Hatchett, Holmes, Duran, & Davis, 2000; Thomas, Simpson, 
Tarver, & Gwede, 2010). Future research is needed to obtain a more in-depth look at 
men’s experience as both CRC patients and FDRs.
The study sample was also limited by its size.  The original goal for this study 
was to recruit thirty patients and thirty FDRs. However, the low numbers of potential 
participants in the sample frames made this goal difficult to reach. Reasons for patient 
non-participation in this study included: 1) patient was too ill to participate, 2) patient did 
not have time, 3) patient was not comfortable talking about his/her diagnosis, 4) patient 
was deceased, 5) patient moved out of state, 6) patient was not interested in participating, 
7) family member interception: family member did not approve of patient’s participation, 
and 8) patient could not be contacted by telephone.  Reasons for FDR non-participation 
included: 1) FDR could not be contacted by telephone, 2) FDR did not have time, 3) FDR 
did not know patient had cancer, and 4) FDR was not interested in participating. Though 
there many reasons for non-participation, questionnaire saturation was reached in both 
phases of the study. However, theoretical saturation was not reached due to the inability 
to reach those patients who practiced total non disclosure. Therefore, the limited sample 
and lack of random selection greatly limit the ability to generalize the findings to all 
African Americans or to African Americans in the southern United States.
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Response bias is another potential problem limiting the ability to generalize 
findings. The response rate for the patient sample was 39% and the response rate for the 
FDR sample was 80%.  Everyone who participated in the study had strong family ties and 
disclosed to at least one family member. It is possible that patients who refused to 
participate were less likely to disclose their diagnosis to family members.  Future 
research is needed to assess the proportion of African American CRC patients who fall 
into each category of disclosure and the reasons for maintaining secrecy.
Social desirability bias is another possible limitation. Participants may have 
adjusted their true feelings and experiences to reflect what they thought was a more 
socially desirable response given the sensitive subject matter.
Finally, the data collected in this study was self-reported and may be prone to 
some inaccuracy. Though the researcher attempted to reduce recall bias by including 
those patients who were diagnosed within the last five years, recall bias is still possible
due to memory lapse or discomfort disclosing personal information. However, 
triangulation of FDRs and patient data helps improve the validity of the patient results.
Recommendations for Further Research
Further study in this area of disclosure is clearly warranted. Next steps could 
include the development of a quantitative instrument that would further capture and 
address the themes noted from the individual interviews. Research that captures the 
similarities and differences in disclosure among other ethnic groups and that examines 
gender differences is also needed. Exploring disclosure for other types of cancers and 
diseases with familial risk might also prove valuable. Preliminary findings also suggest
that additional studies on disease disclosure may make an important contribution to the 
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literature.  For example, would patients be willing to disclose their diagnosis to family 
members if their treatment was not as successful? Future research should also attempt to 
reach those patients who practice total secrecy and find out their reasons for non 
disclosure. This can be explored by attempting to reach patients in a clinic setting. 
Patients may be more likely to discuss non disclosure in a patient setting while 
undergoing treatment than at a later date. Further, it is important to focus on the 
development of culturally-specific educational materials that move beyond the visual 
image of racial/ethnic minority groups on the cover, address some of the attitudes, 
beliefs, and myths about CRC,  and replace the lack of knowledge about CRC with 
factual information (Powe & Adderley-Kelly, 2005).
Conclusions
Using a qualitative research methodology, this study explored the disclosure 
process among African American colorectal cancer survivors and the FDRs with whom 
they shared their diagnosis. In particular the study examined the criteria people use to 
decide when it is appropriate to reveal a CRC diagnosis to family members, how social 
support impacts disclosure, and how social support from patients impacts FDR screening 
beliefs and practices. Sixteen colorectal cancer survivors and sixteen FDRs participated 
in the study.
While most patients said that they were willing to disclose their diagnosis to 
family members, many FDRs felt that the patients did so reluctantly. This study offers a 
unique perspective in that patient and FDR responses were compared to explore the 
experience from both viewpoints. Findings from this study have the potential to: 1) 
advance the lack of knowledge about the dynamics of CRC disclosure to FDRs in African 
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Americans, 2) identify appropriate provider recommendations for disease disclosure and 
communication of familial risk to FDRs, 3) inform the development of culturally relevant 
interventions related to CRC screening, 4) introduce the innovative use of the family 
secrets framework into public health research, and 5) ultimately narrow the CRC health 
disparity among African Americans, especially those with familial risk. This research 
provides valuable insight and information related to the challenges of CRC disease 
disclosure and the impact disclosure has on FDR screening and preventive health among 
African Americans. 
123
References
Afifi, T. D., Olson, L. N., & Armstrong, C. (2005). The chilling effect and family secrets. 
Examining the role of self protection, other protection, and communication 
efficacy. Human Communication Research, 31(4), 564-598.
Agrawal, S., Bhupinderjit, A., Bhutani, M. S., Boardman, L., Nguyen, C., Romero, Y.,
…Figueroa-Moseley, C. (2005). Colorectal cancer in African Americans. 
American Journal of Gastroenterology, 100(3), 515-523; discussion 514.
American Cancer Society. (2007). Cancer facts & figures for African Americans 2007-
2008. Atlanta, GA: Author.
American Cancer Society. (2008). Colorectal cancer facts & figures 2008-2010. Atlanta, 
GA: Author.
American Cancer Society. (2009). Cancer Facts & Figures for African Americans 2009-
2010. Atlanta, GA: Author.
Ballard-Reisch, D. S., & Letner, J. A. (2003). Centering families in cancer 
communication research: Acknowledging the impact of support, culture, and 
process on client/provider communication in cancer management. Patient 
Education and Counseling, 50, 61-66.
Barbour, R. S. (2003). The Newfound credibility of qualitative research? Tales of 
technical essentialism and co-option. Qualitative Health Research, 13, 1019-
1027.
124
Baxter, P., & Jack, S. (2008). Qualitative case study methodology: Study design and 
implementation for novice researchers. The Qualitative Report, 13(4), 544-559.
Blanchard, J., & Lurie, N. (2005). Preventive care in the United States: Are blacks finally 
catching up? Ethnicity and Disease, 15(3), 498-504.
Blocker, D. E., Smith-Romocki, L., Thomas, K. B., Jones, B. L., Jackson, E. J., Reid, L., 
& Campbell, M. K. (2006). Knowledge, beliefs and barriers associated with 
prostate cancer prevention and screening behaviors among African-American 
men. Journal of the National Medical Association, 98(8), 1286-1295.
Bowie, J., Sydnor, K., Granot, M., & Pargament, K. (2004). Spirituality and coping 
among survivors of prostate cancer. Journal of Psychosocial Oncology, 22(2), 41-
56.
Brawley, O. W., & Moore, S. G. (2006). Oncology. In D. Satcher, R. J. Pamies & N. N. 
Woelfl (Eds.), Multicultural Medicine and Health Disparities. New York, NY: 
McGraw-Hill.
Brown-Smith, N. (1998). Family Secrets. Journal of Family Issues, 19(1), 20-42.
Brulle, R. J., & Pellow, D. N. (2006). Environmental justice: Human health and 
environmental inequalities. Annual Reviews Public Health, 27(3), 103-124.
Cardol, M., van Dijk, L., van den Bosch, W., Spreeuwenberg, P., de Bakker, D. H., & 
Greonewegen, P. P. (2007). Striking variation in consultation rates with general 
practice reveal family influence. BMC Family Practice, 8(4), 
Chen, V. W., Fenoglio-Priser, C., Wu, X. C., Coates, R. J., Reynolds, P., Wickerham, D. 
K., …Edwards, B. E. (1997). Aggressiveness of colon carcinoma in blacks and 
whites. Cancer Epidemiology, Biomarkers and Prevention, 6, 1087-1093.
125
Cobb, S. (1976). Presidential address- 1976. Social support as a moderator of life stress. 
Psychosomatic Medicine, 38(5), 300-314.
Corbie-Smith, G., Thomas, S. B., Williams, M. V., & Moody-Ayers, S. (1999). Attitudes 
and beliefs of African Americans toward participation in medical research. 
Journal of General Internal Medicine, 14, 537-546.
Courtenay, W. H. (2000). Constructions of masculinity and their influence on men's well-
being: A theory of gender and health. Social Science and Medicine, 50(10), 1385-
1401.
Creswell, J. W. (2007). Qualitative inquiry & research design: Choosing among five 
approaches. Thousand Oaks, CA: Sage Publications.
d'Agincourt-Canning, L. (2001). Experiences of genetic risk: Disclosure and the 
gendering of responsibility. Bioethics, 15(3), 231-247.
Dey, I. (1999). Grounding grounded theory. San Diego, CA: Academic Press.
Erwin, D. O., Spatz, T. S., Stotts, R. C., Hollenberg, J. A., & Deloney, L. A. (1996). 
Increasing mammography and breast self-examination in African American 
women using the Witness Project model. Journal of Cancer Education, 11(4), 
210-215.
Fiscella, K., & Williams, D. (2004). Health disparities based on socioeconomic 
inequities: Implications for urban health care. Association of American Medical 
Colleges, 79(12), 1139-1147.
Fletcher, R. H. (2002). Successful colorectal cancer screening starts with primary care. 
Reviews in Gastroenterological Disorders, 2(Suppl. 1), 527-534.
126
Forrest, K., Simpson, S. A., Wilson, B. J., van Teijlingen, E. R., McKee, L., Haites, N., & 
Matthews, E. (2003). To tell or not to tell: barriers and facilitators in family 
communication about genetic risk. Clinical Genetics, 64(4), 317-326.
Freeman, H. P. (1998). The meaning of race in science-considerations for cancer 
research: Concerns of special populations in the National Cancer Program. 
Cancer, 82(1), 219-225.
Gili, M., Roca, M., Ferrer, M., Obrador, A., & Cabeza, E. (2006). Psychosocial factors 
associated with the adherence to a colorectal cancer screening program. Cancer 
Detection and Prevention, 30(4), 354-360.
Glaser, B. (1965). The constant comparative method of qualitative analysis. Social 
Problems, 12(436-445).
Gray, R., Fitch, M., Phillips, C., Labrecque, M., & Fergus, K. (2000). To tell or not to 
tell: Patterns of disclosure among men with prostate cancer. Psycho-Oncology, 9,
272-282.
Guest, G., Bunce, A., & Johnson, L. (2006). How many interviews are enough? An 
Experiment with data saturation and variability. Field Methods, 18(1), 59-82.
Guion, L. A. (2001). Conducting an in-depth interview. Retrieved from 
http://edis.ifas.ufl.edu/FY393
H. Lee Moffitt Cancer Center & Research Institute. (2007). 2006 cancer registry annual 
report. Tampa, FL.
Hallowell, N., Ardern-Jones, A., Eeles, R., Foster, C., Lucassen, A., Moynhan, C., & 
Watson, C. (2005). Communication about genetic testing in families of male 
127
BRCA1/2 carriers and non-carriers: patterns, priorities and problems. Clinical 
Genetics, 67(6), 492-502.
Hatchett, B. F., Holmes, K., Duran, D. A., & Davis, C. (2000). African Americans and 
research participation: The recruitment process. Journal of Black Studies, 30(5), 
664-675.
Henderson, B. N., Davison, K. P., Pennebaker, J. W., Gatchel, R. J., & Baum, A. (2002). 
Disease disclosure patterns among breast cancer patients. Psychology and Health, 
17(1), 51-62.
Hilton, S., Emsile, C., Hunt, K., Chapple, A., & Ziebland, S. (2009). Disclosing a cancer 
diagnosis to friends and family: A gendered analysis of young men's and women's 
experiences. Qualitative Health Research, 19(6), 744-754.
Honda, K., & Kagawa-Singer, M. (2006). Cognitive mediators linking social support 
networks to colorectal cancer screening adherence. Journal of Behavioral 
Medicine, 29(5), 449-459.
House, J. S. (1981). Work, Stress, and Social Support. Reading, MA: Addison-Wesley.
Jacobsen, J., & Jackson, V. A. (2009). A communication approach for oncologists: 
Understanding patient coping and communicating about bad news, palliative care, 
and hospice. Journal of the National Comprehensive Cancer Network, 7(4), 475-
480.
Jones, C. P. (2000). Levels of racism: A theoretic framework and a gardener's tale. 
American Journal of Public Health, 90(8), 1212-1215.
Julian-Reynier, C., Eisinger, F., Chabal, F., Lasset, C., Nogues, C., Stoppa-Lyonnet, D.,
…Sobol, H. (2000). Disclosure to the family of breast/ovarian cancer genetic test 
128
results: Patient's willingness and associated factors. American Journal of Medical 
Genetics, 94(1), 13-18.
Kanna, B., Schori, M., Azeez, S., Kumar, S., & Soni, A. (2007). Colorectal tumors within 
an urban minority population in New York City. Journal of General Internal 
Medicine, 22(6), 835-840.
Kinney, A. Y., Bloor, L. E., Martin, C., & Sandler, R. S. (2005). Social ties and 
colorectal cancer screening among blacks and whites in North Carolina. Cancer 
Epidemiology, Biomarkers and Prevention, 14(1), 182-189.
Kreueter, M. W., Lukwago, S., Bucholtz, D., Clark, E., Sanders-Thompson, V. (2003). 
Achieving cultural appropriateness in health promotion program: Targeted and 
tailored approaches. Health Education & Behavior, 30(2), 133-146.
Kreuter, M. W., & Haughton, L. T. (2006). Integrating culture into health information for 
African American women. American Behavioral Scientist, 49(6), 794-811.
Kupfer, S. S., McCaffrey, S., & Kim, K. E. (2006). Racial and gender disparities in 
heredity colorectal cancer risk assessment: the role of family history. Journal of 
Cancer Education, 21(1 Suppl.), S32-36.
Levin, B., Lieberman, D. A., McFarland, B., Andrews, K. S., Brooks, D., Bond, J., 
…Winawer, S. J. (2008). Screening and surveillance for the early detection of 
colorectal cancer and adenomatous polyps, 2008: A joint guideline from the 
American Cancer Society, the US Multi-Society Task Force on Colorectal 
Cancer, and the American College of Radiology. Gastroenterology, 134(5), 1570-
1595.
129
Madlensky, L., Esplen, M. J., Gallinger, S., McLaughlin, J. R., & Goel, V. (2003). 
Relatives of colorectal cancer patients. American Journal of Preventive Medicine, 
25(3), 187-194.
Murff, H. J., Peterson, N. B., Greevy, R. A., Shrubsole, M. J., & Zheng, W. (2008). Early 
initiation of colorectal cancer screening in individuals with affected first-degree 
relatives. Journal of General Internal Medicine, 22(1), 121-126.
National Cancer Institute. (2008, October 17, 2008). Colorectal cancer screening: 
Questions and answers. Retrieved from 
http://www.cancer.gov/cancertopics/factsheet/Detection/colorectal-screening
National Center for Health Statistics. (2009). Health, United States, 2009 with special 
feature on medical technology. Hyattsville, MD: Centers for Disease Control and 
Prevention.
National Institutes of Health. (2009, Aug 4 2009). Health Disparities Defined Retrieved 
from http://crchd.cancer.gov/disparities/defined.html
Neuman, W. L. (2003). Social research methods: Qualitative and quantitative 
approaches (5 ed.). Boston, MD: Pearson Education, Inc.
Oluwole, S. F., Ali, A. O., Adu, A., Blane, B. P., Barlow, B., Oropeza, R., & Freeman, H. 
P. (2003). Impact of a cancer screening program on breast cancer stage at 
diagnosis in a medically underserved urban community. Journal of the American 
College of Surgeons, 196(2), 180-188.
Plowden, K., & Miller, J. (2000). Motivators of health seeking behavior in urban African-
American men: an exploration of triggers and barriers. Journal of the National 
Black Nurses Association, 11(1), 15-20.
130
Powe, B., & Adderley-Kelly, B. (2005). Colorectal cancer in African-Americans: 
Addressing the need for further research and research utilization. Journal of 
National Black Nurses Association, 16(1), 48-54.
Read, T. E., & Kodner, I. J. (1999). Colorectal cancer: Risk factors and recommendations 
for early detection. American Family Physician, 59(11), 2979-2980.
Rex, D. K. (2002). Current colorectal cancer screening strategies: Overview and 
obstacles to implementation. Reviews in Gastroenterological Disorders, 2(1), 2-
11.
Robillard, A. G., & Larkey, L. (2009). Health disadvantages in colorectal cancer 
screening among African Americans: Considering the cultural context of narrative 
health promotion. Journal of Health Care for the Poor and Underserved, 20(2 
Suppl), 102-119.
Rubin, D. T., Gandhi, R. K., Hetzel, J. T., Kinnear, S. H., Aronsohn, A., Wood, G., & 
Yadron, N. (2009). Do colorectal cancer patients understand that their family is at 
risk? Digestive Diseases and Sciences, 54(11), 2473-2483.
Salminen, M., Vahlberg, T., Ojanlatva, A., & Kivela, S. (2005). Effects of cotrolled 
family-based health education counsing intervention. American Journal of Health 
Behavior, 29(5), 395-406.
Sandelowski, M. (1995). Sample size in qualitative research. Research in Nursing and 
Health, 18(2), 179-183.
Smedley, B. D., Stith, A. Y., & Nelson, A. R. (Eds.). (2003). Unequal treatment: 
Confronting racial and ethnic disparities in healthcare. Washington, DC: 
National Academies Press.
131
St. Joseph's Hospital. (2010). Cancer Institute. Retrieved from 
http://www.sjbhealth.org/body.cfm?id=22
Strauss, A., & Corbin, C. (1994). Grounded theory methodology: An overview. In N. K. 
Denzin, Lincoln, Y.S. (Ed.), Handbook of Qualitative Research (pp. 273-285). 
London: Sage.
Thomas, K. B., Simpson, S. L., Tarver, W. L., & Gwede, C. K. (2010). Is Social Support 
From Family Associated With PSA Testing? An Exploratory Analysis Using the 
Health Information National Trends Survey (HINTS) 2005. American Journal of 
Men's Health, 4(1), 50-59.
U.S. Preventive Services Task Force. (2008). Screening for colorectal cancer: U.S. 
Preventive Services Task Force recommendation statement. Annals of Internal 
Medicine, 149(9), 627-637.
Vangelisti, A., Caughlin, J., & Timmerman, L. (2001). Criteria for revealing family 
secret. Communication Monographs, 68(1), 1-27.
Vernon, S. W. (1997). Participation in colorectal cancer screening: A review. Journal of 
the National Cancer Institute, 89(19), 1406-1422.
Wagner Costalas, J., Itzen, M., Malick, J., Babb, J., Bove, B., Godwin, A., & Daly, M. B. 
(2003). Communication of BRCA1 and BRCA2 results to at-risk relatives: A 
cancer risk assessment program's experience. American Journal of Medical 
Genetics. Part C, Seminars in Medical Genetics, 119(1), 11-18.
WHO Study Group on Statistical Indices of Family Health. (1976). Statistical indices of 
family health Geneva, Switzerland: World Health Organization.
132
Appendices
133
Appendix A: Concept Chart
134
Appendix B: IRB Approval Letters
135
Appendix B: (Continued)
136
Appendix B: (Continued)
137
Appendix C: Recruitment Letters
138
Appendix C: (Continued)
139
Appendix C: (Continued)
140
Appendix D: Informed Consent
141
Appendix D: (Continued)
142
Appendix D: (Continued)
143
Appendix D: (Continued)
144
Appendix D: (Continued)
145
Appendix D: (Continued)
146
Appendix D: (Continued)
147
Appendix D: (Continued)
148
Appendix D: (Continued)
149
Appendix D: (Continued)
150
Appendix D: (Continued)
151
Appendix D: (Continued)
152
Appendix D: (Continued)
153
Appendix D: (Continued)
154
Appendix D: (Continued)
155
Appendix D: (Continued)
156
Appendix D: (Continued)
157
Appendix D: (Continued)
158
Appendix D: (Continued)
159
Appendix D: (Continued)
160
Appendix D: (Continued)
161
Appendix D: (Continued)
162
Appendix D: (Continued)
163
Appendix E: Interview Guides
Patient Interview Guide
I want to thank you for taking the time to meet with me today. My name is 
Kamilah and I would like to talk to you about how you decided who to tell about your 
colorectal cancer diagnosis and how the process went for you. Your insight and opinions 
on this subject will be used to help other people who have to face similar decisions after 
learning they have colorectal cancer. There are no right or wrong answers, so please say 
what's on your mind and what you think. 
The portion of the interview should take about half an hour. I will be taping the 
session because I don’t want to miss any of your comments. Although I will be taking 
some notes during the session, I can’t possibly write fast enough to get it all down. 
Because we’re on tape, please be sure to speak up so that we don’t miss your comments. 
All responses will be kept confidential. This means that your interview responses will 
only be shared with research team members and we will ensure that any information we 
include in our report does not identify you as the respondent. Remember, you don’t have 
to talk about anything you don’t want to and you may end the interview at any time.
I hope you will feel comfortable here today and share all of your opinions, both positive 
and negative.  We value all your ideas. Do you have any questions about this study or 
today's interview? 
Okay, let's begin.
1) Can you think back to when you were first diagnosed with Colorectal Cancer and tell 
me about your experience?
2) When you first learned about your Colorectal Cancer diagnosis what were the first 3 
things that came to mind?
3) Which first degree relatives (parents, siblings, children) did you decide to tell? (make 
list) 
4) What was the decision of who to tell like for you? (Probe: What was hard, easy? What 
factors did you consider?)
5) What was the major reason you decided to tell ____? 
6) How did it go when you told him/her?
7) Think back to when you revealed your diagnosis, when did you feel it was an 
appropriate time to reveal your diagnosis? What type of setting was helpful? (Probe: 
Were you at home? Was it over the phone? Was it quiet?)
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8) How did you feel when you revealed your Colorectal Cancer diagnosis?
9) How did you expect people to respond? What did you hope would happen (Probe: Did 
you want them to show that they loved you, cared for you, in what way?; Did you hope 
they would take you to appointments, help you cook or clean?; Did you want them to find 
out more about CRC or get more information for you?; Did you want them to tell you 
that you were handling the news of your illness well or that it wasn’t your fault)
10) How did they actually respond or react to the news? What did s/he say? What did 
s/he do?
11) How were your family member’s responses like each other and how were they 
different from each other?
12) Now I want to ask you about after your treatment. Since your treatment ended, how 
has your family responded to you?
13) How do you feel now about your decision to share your diagnosis with him/her? 
(Probe: Are you glad/sorry you shared it with them? Why?)
14) Were there any relatives that you didn’t tell about your colorectal cancer diagnosis?
15) What made you not tell those relatives? Do you wish you had told them? Why do you 
say that? 
16) As you think back about all of the experiences that we have discussed today, what 
type of effect do you think disclosing your Colorectal Cancer Diagnosis has had on your 
relatives?  (Probe: What about their decisions to get screened?) 
17) Do you know if any of your relatives got screened after you told them? (Probe: Who? 
What did they tell you about their decision to be screened? 
18) How did discussing your diagnosis of Colorectal Cancer compare to other secrets or 
private information that you had to share with family members in the past?
19) When you think of Colorectal Cancer now, what 3 things come to mind?
That was a great conversation. I am really thankful for all your input and honesty. You 
were very helpful. Do you have any questions for me? Thank you for your time. If any 
questions come up, you may contact me at the number or email on your fact sheet.
165
Appendix E:  (Continued)
FDR Telephone Interview Guide
I want to thank you for allowing me to call you today. My name is Kamilah and I would 
like to talk to you about your experience with learning about your family member’s 
colorectal cancer diagnosis and how that process went for you. Your insight and opinions 
on this subject will be used to help other people who have to face similar situations after 
learning about their family member’s diagnosis. There are no right or wrong answers, so 
please say what's on your mind and what you think. 
This portion of the interview should take less than an hour. I will be taping the session
because I don’t want to miss any of your comments. Although I will be taking some notes 
during the session, I can’t possibly write fast enough to get it all down. Because we’re on 
tape, please be sure to speak up so that we don’t miss your comments. All responses will 
be kept confidential. This means that your interview responses will only be shared with 
research team members and we will ensure that any information we include in our report 
does not identify you as the respondent. Remember, you don’t have to talk about 
anything you don’t want to and you may end the interview at any time.
I hope you will feel comfortable here today and share all of your opinions, both positive 
and negative.  We value all your ideas. Do you have any questions about this study or 
today's interview? 
Okay, let's begin.
1. Can you tell me about when you first learned that ______ had Colorectal Caner? 
2. When you first learned about your relative’s Colorectal Cancer diagnosis what were 
the first 3 things that came to mind?
3. Who told you that s/he had Colorectal Cancer?
4. Why do you think s/he told you? (Probe: Did they worry about survival or recovery?; 
Was the news too stressful to not share?)
5. Was the environment good for that type of conversation? What was good or bad about 
the time and place that you were told?
6. How did you react when you first learned about the Colorectal Cancer diagnosis? 
(Probe: Were you empathetic?; Did you offer to do anything to help (like cooking, 
cleaning)?; Did you offer advice?; Did you tell them that they handling the news of 
cancer in a good way?)
7. What impact did this news have on you? Did you do anything differently?
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8. What do you think your family member expected from you by telling you about their 
diagnosis? 
9. Have you personally been screened for CRC? Was that before or after learning about 
____’s Colorectal Cancer diagnosis? ; How long after? What made you go at that time?
10. What impact did the diagnosed patient have on your decision (or not) to get screened? 
11. Did they do anything to encourage you to be screened? (Probe: Did they care if you 
were screened? Did they give you information on where to get screened? Did they offer 
to take you to get screened? Did they make you feel good about being screened?) 
12. When you think of CRC now, what comes to mind?
That was a great conversation. I am really thankful for all your input and honesty. You 
were 
very helpful. Do you have any questions for me? Thank you for your time. If any 
questions come up, you may contact me at the number or email on your consent form.
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